Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
MMP26	"endometase, MGC126590, MGC126592"	ENSG00000167346	"Matrix metallopeptidase 26"	Q9NRE1	11	4704927-4992429	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	13	"endometrium 1: 19.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"endometrial cancer: 8.8;prostate cancer: 2.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to extracellular matrix"									"unprognostic (4.21e-3)"								"unprognostic (2.63e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.4	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PAEP	"GD, GdA, GdF, GdS, MGC138509, MGC142288, PAEG, PEP, PP14"	ENSG00000122133	"Progestagen associated endometrial protein"	P09466	9	135561756-135566955	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"ductus deferens: 176.9;endometrium 1: 79.9;placenta: 105.3"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 21.5"	"Cancer enriched"	"Detected in many"	8	"melanoma: 275.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 5.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.8"									"CAB016762, HPA020108, HPA029473"	Enhanced				"Secreted in female reproductive system"					"CAB016762: , HPA020108: AB_1855595, HPA029473: AB_10610147"	"unprognostic (3.39e-2)"	"unprognostic (8.47e-3)"	"unprognostic (6.84e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (6.61e-6)"	"unprognostic (1.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.93e-3)"		"prognostic unfavourable (0.00e+0)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (4.24e-1)"		"unprognostic (4.98e-2)"	0.3	0.1	0.1	0.2	0.1	0.4	0.3	0.1	0.2	1.3	0.1	0.0	176.9	0.2	79.9	0.1	0.1	5.0	0.0	0.1	0.1	0.3	0.1	0.3	0.4	0.0	0.1	0.0	0.8	0.1	0.0	0.2	105.3	0.0	1.1	0.0	0.0	0.2	13.9	0.1	1.1	0.1	0.0	0.1	0.2	2.0	0.5	0.0	0.0	0.1	0.0	0.0	0.8	0.1	1.3	1.3	5.8	0.9	0.8	0.8	0.3	0.1	0.5	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.7	0.5	0.4	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.6	2.3	0.0	0.5	0.0	0.1	0.0	0.0	0.1	3.0	0.5	0.0	0.3	0.0	0.7	0.5	0.0	0.2	0.2	0.4	0.0	0.1	0.4	0.2	0.1	0.2	21.5	0.4	0.2	0.0	0.1	1.1	0.2	0.1	1.0	2.0	0.2	0.3	0.3	0.4	5.8	0.9	0.6	0.6	0.5	0.5	0.6	0.8	0.6	0.3	1.3	0.7	0.8	4.0	0.8	0.8	1.3	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.0	0.0	0.0
TEX15	CT42	ENSG00000133863	"Testis expressed 15, meiosis and synapsis associated"	Q9BXT5	8	30831544-30913003	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 5.4;endometrium 1: 10.0;pituitary gland: 6.9;smooth muscle: 8.5;testis: 21.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.7;HEL: 19.7;K-562: 5.5;NTERA-2: 3.7;SCLC-21H: 4.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA036800	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA036800: AB_10671714"	"unprognostic (3.10e-1)"	"unprognostic (2.56e-1)"		"unprognostic (3.30e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-5)"	"unprognostic (8.88e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.92e-1)"	0.1	0.1	0.7	0.2	5.4	0.1	0.1	0.1	1.1	1.2	0.1	0.0	0.0	0.1	10.0	0.6	0.2	0.1	0.8	0.1	1.7	0.5	0.1	0.1	0.1	0.1	0.3	0.3	0.4	0.1	0.1	6.9	0.1	0.9	0.1	0.1	0.3	0.1	0.5	0.1	0.1	0.2	8.5	0.4	0.4	0.9	21.3	1.4	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	8.7	1.1	0.0	1.1	3.1	19.7	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.1	0.1	0.1	3.7	0.3	0.0	0.0	0.0	0.0	0.0	4.3	1.4	0.0	0.0	3.7	0.2	1.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.4	0.1	1.1	1.7	0.5	0.3	0.3	0.9	1.4
C2CD4A	"FAM148A, NLF1"	ENSG00000198535	"C2 calcium dependent domain containing 4A"	Q8NCU7	15	62066977-62070917	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"endometrium 1: 6.8;liver: 25.9;pancreas: 20.4;pituitary gland: 21.9"	"Cell line enriched"	"Detected in some"	18	"RPTEC TERT1: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																						"unprognostic (3.85e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.38e-3)"	"unprognostic (5.49e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (4.72e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.35e-1)"	0.3	1.0	0.5	1.3	0.4	0.3	0.5	0.2	0.7	1.0	1.2	0.1	0.1	2.2	6.8	0.3	0.2	0.1	0.9	0.2	0.4	0.9	2.5	25.9	2.0	0.3	0.3	0.1	0.4	20.4	0.0	21.9	0.8	1.3	1.1	1.4	0.2	1.2	0.1	0.8	1.1	1.1	0.1	0.4	0.2	2.2	0.2	0.1	1.2	0.9	0.1	1.2	1.3	0.1	0.8	0.9	2.5	0.5	0.9	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.9	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	25.8	0.6	1.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.2	0.5	0.4	0.4	0.2	0.4	0.5	0.4	0.2	0.1	0.8	0.5	0.3	2.5	0.9	0.2	0.9	1.0	0.1	0.5	0.4	0.2	0.4	0.4	0.9	0.3	0.1	1.3	0.1
C1QTNF6	"CTRP6, ZACRP6"	ENSG00000133466	"C1q and TNF related 6"	Q9BXI9	22	37180167-37199385	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"endometrium 1: 23.7;placenta: 79.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 44.0;RT4: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA002042	Enhanced		Approved	Nucleoplasm	"Secreted to blood"			Nucleoplasm	Nucleoplasm	"HPA002042: AB_1078342"	"unprognostic (9.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.23e-3)"	"unprognostic (1.25e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (9.60e-6)"	"unprognostic (6.96e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.61e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.52e-2)"	3.3	4.4	1.2	4.2	1.6	0.8	2.5	1.2	1.8	7.8	2.5	1.3	1.6	1.0	23.7	7.2	1.6	5.2	6.2	3.1	1.4	0.7	3.9	7.9	9.2	3.1	1.2	1.3	5.9	2.3	1.4	1.4	79.5	1.7	4.3	2.5	4.4	2.2	3.4	1.5	3.1	3.2	5.7	1.8	4.6	1.8	3.5	1.2	1.6	2.4	1.7	1.8	5.1	2.7	2.4	1.1	1.8	0.5	4.0	3.8	1.0	6.6	8.2	4.3	1.5	0.7	8.7	13.1	1.4	2.7	1.1	0.8	1.5	9.7	0.0	5.6	2.3	13.7	0.1	3.3	0.5	1.9	1.0	1.0	3.1	1.5	3.0	0.0	0.9	12.0	1.9	0.9	0.2	10.3	0.0	3.1	0.4	44.0	0.0	0.2	2.7	0.1	0.1	0.0	1.1	10.0	20.4	0.7	5.6	0.4	7.9	1.1	2.8	0.2	3.5	0.4	2.2	0.1	0.0	6.4	0.1	0.0	0.8	0.8	1.2	1.0	0.5	1.5	0.7	0.5	0.8	0.8	1.3	1.0	0.5	2.4	2.9	2.2	1.8	4.0	0.3	1.1	3.8	1.0	1.2	1.6	1.2	1.8	1.4	0.7	1.2	1.3	1.7	1.2
CDC20B	FLJ37927	ENSG00000164287	"Cell division cycle 20B"	Q86Y33	5	55112995-55173175	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"endometrium 1: 1.8;fallopian tube: 5.5;kidney: 2.9;lung: 4.9;testis: 6.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.4;T-47d: 3.3;U-87 MG: 1.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hypothalamus: 0.4"					HPA053900	Uncertain									"HPA053900: AB_2682299"	"unprognostic (7.39e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.15e-4)"	"unprognostic (1.99e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.29e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.8	0.1	0.1	5.5	0.1	0.1	0.1	0.1	2.9	0.1	4.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	6.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.1	0.4	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.3	3.3	0.0	0.4	0.0	0.2	0.7	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076993-132128020	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"endometrium 1: 7.4;kidney: 6.6;smooth muscle: 5.5"	"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HSkMC: 1.7;U-87 MG: 5.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	29	"olfactory region: 80.8"	"Region enriched"	"Detected in single"	100	"olfactory region: 45.5"	HPA000886	Uncertain									"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0			0.0	7.4	1.1	0.0	1.1	0.0	0.1	0.0	0.1	6.6	1.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.5	0.0		0.0	1.1	0.0	0.5	0.0	5.5	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0										
GPR139	PGR3	ENSG00000180269	"G protein-coupled receptor 139"	Q6DWJ6	16	20031485-20073917	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 2.8;endometrium 1: 2.1;smooth muscle: 1.0"	"Cell line enriched"	"Detected in single"	10	"NTERA-2: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA046596	Uncertain									"HPA046596: AB_2679713"					"unprognostic (2.94e-1)"													0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0			0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.2	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MMP11	STMY3	ENSG00000099953	"Matrix metallopeptidase 11"	P24347	22	23768226-23784316	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"endometrium 1: 44.1;placenta: 119.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 18.9;BJ hTERT+: 5.1;REH: 7.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 7.8"	"Group enriched"	"Detected in many"	5	"B-cells: 2.4;dendritic cells: 7.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002593, HPA068864"	Approved				"Secreted to extracellular matrix"					"CAB002593: , HPA068864: AB_2686051"	"unprognostic (1.06e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.15e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavourable (2.62e-4)"	"unprognostic (8.05e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-2)"	1.7	0.6	0.2	1.0	0.6	0.1	1.6	1.0	0.5	13.4	1.8	0.4	0.4	1.9	44.1	1.1	0.8	2.2	2.0	3.1	0.5	0.0	1.7	0.5	0.7	1.8	0.4	0.2	7.7	1.1	0.2	0.3	119.6	0.5	1.4	1.0	0.8	2.5	0.4	0.5	2.0	4.0	2.7	0.3	0.9	0.7	3.4	0.2	2.6	0.5	0.6	0.9	1.6	2.1	2.4	7.8	0.0	0.0	0.0	1.0	0.1	0.1	0.0	2.3	18.9	2.9	4.2	0.0	0.2	5.1	0.6	0.4	0.0	0.6	0.6	3.5	1.3	0.1	1.0	0.0	0.2	0.0	0.3	0.0	0.0	1.0	2.1	0.0	0.0	2.7	0.4	0.5	0.0	3.0	0.3	0.0	0.7	0.1	0.0	0.0	0.7	0.1	7.9	0.0	0.2	0.3	0.0	3.0	5.1	1.9	0.3	0.0	1.8	0.0	1.3	0.3	0.0	0.8	0.0	0.1	0.1	2.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.4	1.0	0.3	0.0	0.0	0.0	7.8	0.0	0.1	0.2	0.6	1.0	0.5	0.5	0.0	0.4	0.2	0.5	0.2
CEMIP	"HYBID, IR2155535, KIAA1199, TMEM2L"	ENSG00000103888	"Cell migration inducing hyaluronan binding protein"	Q8WUJ3	15	80779343-80951776	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"endometrium 1: 33.9;lymphoid tissue: 116.9"	"Group enriched"	"Detected in some"	5	"BJ: 43.3;BJ hTERT+: 68.5;fHDF/TERT166: 54.4;HSkMC: 37.4;U-138 MG: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	560000	560000				"unprognostic (1.14e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.27e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (2.65e-4)"	6.7	2.1	1.7	11.6	5.0	1.7	1.0	6.8	8.9	2.4	6.9	6.4	2.6	1.2	33.9	7.8	7.1	7.0	2.8	6.4	2.2	2.8	1.1	1.0	16.6	116.9	14.1	9.4	5.3	1.4	0.7	9.1	2.9	15.6	2.5	2.4	15.4	5.9	3.2	4.3	6.2	1.6	0.9	13.6	2.0	1.3	3.3	1.1	0.0	4.4	0.7	5.0	6.5	3.1	0.9	1.5	0.6	0.5	0.2	1.3	0.2	0.1	1.6	0.3	0.2	0.1	0.6	0.2	43.3	68.5	1.1	0.9	0.5	0.2	0.2	0.1	54.4	1.0	0.0	0.1	0.2	0.1	0.4	0.1	0.2	3.5	0.4	0.1	0.2	37.4	0.0	8.5	0.0	0.0	0.2	0.1	1.0	0.9	0.1	0.1	0.2	1.9	0.2	0.0	0.1	0.0	0.7	2.7	0.1	0.7	0.1	3.6	0.2	0.0	0.2	19.8	0.2	1.4	0.7	0.1	0.1	0.2	2.1	0.3	1.3	0.0	0.3	0.0	0.4	0.4	0.1	0.6	0.0	0.2	0.0	0.9	0.0	0.7	0.6	0.2	0.5	1.5	1.3	0.2	1.7	5.0	6.8	8.9	2.2	2.8	14.1	9.4	15.6	1.1
PGR	"NR3C3, PR"	ENSG00000082175	"Progesterone receptor"	P06401	11	101029624-101130524	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 50.7;endometrium 1: 116.4;smooth muscle: 31.2"	"Cell line enriched"	"Detected in single"	349	"T-47d: 60.8"	"Group enriched"	"Detected in some"	13	"breast cancer: 10.1;endometrial cancer: 11.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000068, HPA004751, HPA008428, HPA017176, CAB055100"	Enhanced									"CAB000068: AB_442124, CAB055100: AB_2532076, HPA004751: AB_1079681, HPA008428: AB_1079680, HPA017176: AB_1855728"	"unprognostic (2.59e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.23e-3)"	"prognostic favourable (5.76e-8)"	"unprognostic (2.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.71e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.44e-3)"	0.8	0.7	0.2	0.3	0.6	0.0	5.0	0.2	0.7	50.7	1.3	0.2	0.4	0.0	116.4	6.1	0.5	13.2	0.4	2.0	0.5	0.6	0.4	0.1	1.2	0.3	0.4	0.1	10.6	0.8	0.0	2.8	1.8	0.8	3.8	0.1	0.7	3.5	5.5	0.3	0.3	1.2	31.2	0.9	0.5	0.4	1.5	0.3	0.1	0.3	0.8	0.2	1.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.7	0.5	0.6	0.4	0.1	0.8	0.3
ZCCHC12	"FLJ16123, PNMA7A, SIZN, SIZN1"	ENSG00000174460	"Zinc finger CCHC-type containing 12"	Q6PEW1	X	118823790-118826968	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 51.3;endometrium 1: 53.4;fallopian tube: 60.7;smooth muscle: 72.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.4;HEK 293: 13.9;NTERA-2: 4.4;SH-SY5Y: 3.5"	"Cancer enriched"	"Detected in many"	76	"thyroid cancer: 256.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"naive CD8 T-cell: 4.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.1"									"HPA031016, HPA034940"	Uncertain		Approved	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA031016: AB_2673698, HPA034940: AB_10671098"	"unprognostic (1.29e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.34e-4)"	"unprognostic (9.18e-13)"	"unprognostic (4.14e-3)"	"unprognostic (1.63e-1)"	"prognostic favourable (3.42e-5)"	"unprognostic (1.18e-1)"	0.9	4.8	30.5	1.2	20.2	0.8	1.0	20.3	17.3	9.7	1.1	1.6	0.9	1.0	53.4	11.6	0.8	60.7	1.0	0.8	28.7	51.3	0.8	0.8	0.9	1.1	4.4	11.6	6.7	0.8	0.8	7.9	0.8	14.7	1.0	1.0	1.1	0.8	1.1	0.8	0.8	1.1	72.5	4.5	0.9	0.8	1.0	0.8	0.0	2.9	0.0	1.1	0.8	1.7	0.6	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	0.4	0.0	0.0	5.4	0.0	0.2	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.2	4.4	0.0	0.1	0.0	0.0	0.0	0.0	1.9	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.7	4.1	0.0	0.0	0.0	0.0	0.0	0.2	30.5	20.2	20.3	17.3	28.7	51.3	4.4	11.6	14.7	0.8
ASIC2	"ACCN, ACCN1, ASIC2a, BNaC1, BNC1, hBNaC1, MDEG"	ENSG00000108684	"Acid sensing ion channel subunit 2"	Q16515	17	33013087-34174964	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 13.1;cervix, uterine: 6.8;endometrium 1: 9.5;smooth muscle: 3.9"	"Group enriched"	"Detected in some"	4	"NTERA-2: 4.2;PC-3: 1.1;RPTEC TERT1: 3.8"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052112	Enhanced									"HPA052112: AB_2681733"	"unprognostic (3.40e-1)"	"unprognostic (2.45e-2)"	"unprognostic (8.50e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.29e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	0.4	1.9	8.1	0.4	6.3	0.3	0.7	8.7	13.1	6.8	0.7	1.1	0.0	1.2	9.5	0.5	0.4	1.5	0.5	0.4	7.7	10.0	1.2	0.4	0.5	0.4	4.6	5.5	0.4	0.4	0.3	0.5	0.5	3.7	0.6	0.8	0.2	0.3	1.7	0.3	0.6	1.2	3.9	2.3	0.4	0.5	1.1	0.8	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	1.1	0.0	0.0	0.5	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	6.3	8.7	9.6	7.7	10.0	4.6	5.5	3.7	0.8
LEFTY2	"EBAF, LEFTA, LEFTYA, TGFB4"	ENSG00000143768	"Left-right determination factor 2"	O00292	1	225936598-225941489	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"endometrium 1: 61.1;ovary: 80.0"	"Group enriched"	"Detected in some"	5	"NTERA-2: 24.7;RPMI-8226: 26.6"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 41.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"											"CAB025801, HPA047883, HPA056210"	Approved				"Secreted in other tissues"					"CAB025801: , HPA047883: AB_2680200, HPA056210: "	"unprognostic (3.78e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.79e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.75e-4)"	"unprognostic (2.91e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.90e-4)"	"unprognostic (1.64e-3)"	0.5	0.4	0.1	0.3	0.2	0.0	0.5	0.1	0.2	15.2	0.5	0.7	0.1	0.0	61.1	4.5	0.2	1.1	0.1	0.8	0.4	0.0	0.4	0.1	0.7	0.1	0.2	0.1	80.0	0.1	0.0	8.5	16.3	0.6	0.9	0.0	0.9	0.1	4.4	0.2	0.0	0.2	14.7	0.1	0.1	0.0	1.8	0.1	0.3	0.1	0.1	0.1	0.3	0.5	0.5	0.0	0.9	0.0	0.1	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	24.7	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	1.4	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.7	0.8	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.1	0.2	0.4	0.0	0.2	0.1	0.6	0.1
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770503-102780628	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"endometrium 1: 89.4"	"Cell line enhanced"	"Detected in some"		"BJ: 12.3;HUVEC TERT2: 15.8;SCLC-21H: 5.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 102.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"			Cytosol	Cytosol	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favourable (7.12e-4)"	0.1	0.1	0.0	2.6	0.2	0.1	0.1	0.0	0.3	1.7	0.5	0.0	0.0	0.4	89.4	0.1	0.2	0.1	0.5	0.1	0.0	0.1	0.1	3.6	11.0	0.1	0.0	0.0	0.5	0.3	0.1	0.9	19.8	2.8	3.2	0.2	0.0	2.9	0.1	0.1	0.1	0.7	0.1	0.0	0.2	3.3	0.5	0.0	1.2	0.1	0.0	1.9	0.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.2	12.3	0.7	0.1	0.1	0.3	0.0	0.0	3.6	1.9	2.8	0.0	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.6	15.8	0.7	0.0	0.0	0.0	0.0	0.3	2.9	1.7	0.0	0.0	0.0	0.0	0.7	5.0	0.0	2.5	0.0	0.0	0.0	0.0	2.0	3.8	1.2	0.4	0.5	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	2.8	0.0
SCGB1D4	IIS	ENSG00000197745	"Secretoglobin family 1D member 4"	Q6XE38	11	62296277-62299064	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"cervix, uterine: 27.5;ductus deferens: 9.9;endometrium 1: 9.5;epididymis: 27.9;fallopian tube: 36.8"	"Group enriched"	"Detected in some"	20	"HL-60: 3.1;Karpas-707: 1.0;RPMI-8226: 1.8"	"Cancer enriched"	"Detected in some"	57	"endometrial cancer: 100.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in female reproductive system"									"unprognostic (2.26e-3)"						"unprognostic (3.20e-1)"								0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	27.5	0.1	0.1	9.9	0.0	9.5	27.9	0.1	36.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	5.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
AC004080.3		ENSG00000257184			7	27163535-27180013	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"cervix, uterine: 24.9;endometrium 1: 20.7;prostate: 12.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.8;BJ: 4.3;BJ hTERT+ SV40 Large T+: 1.5;HEK 293: 2.9;RPTEC TERT1: 2.2;U-937: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																								"unprognostic (4.27e-1)"									"unprognostic (4.63e-1)"		"unprognostic (4.49e-1)"				1.6	0.2	0.3	1.8	0.3	0.0	0.2	0.3	0.3	24.9	6.9	0.0	1.0	0.0	20.7	2.1	0.2	0.2	0.0	0.3	0.2	0.3	4.7	0.3	0.2	0.0	0.3	0.0	0.3	0.3	0.0	0.3	4.6	0.0	12.9	1.1	0.0	0.2	1.2	6.9	0.3	0.5	6.7	0.2	0.2	0.2	1.0	0.0	0.0	0.3	0.0	0.0	7.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.2	0.2	4.3	0.8	1.5	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.0	0.0	0.0
AC008403.1		ENSG00000268465			19	48465837-48472431	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.7;intestine: 3.6;testis: 4.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.9;LHCN-M2: 3.6;NB-4: 3.7;U-698: 5.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA060662			Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA060662: AB_2732652"																		0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.5	0.1	3.6			0.0	2.7	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.2		0.3	0.0	0.0	0.1	0.0		0.3	0.0		0.1	0.0	0.3	0.1	1.6	0.0	0.2	0.1	0.5	4.7			0.1		0.0	0.0	0.0	1.0	0.5	0.7	0.4	0.0	1.0	0.0	0.0	0.0	0.0	2.9	2.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.6	2.3	1.3	0.0	2.2	0.0	0.0	1.2	0.0	0.0	0.3	0.0	3.6	0.0	0.0	3.7	1.9	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.2	0.0	1.5	0.1	0.0	0.0	0.0	0.9	1.8	0.0	0.0	0.9	0.9	5.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.3	0.2	1.0	0.3	0.4	0.3	0.0	0.6	0.1	0.0	0.0	0.4	0.5	1.0	0.0										
AC243756.1		ENSG00000270339			1	146344131-146344790	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 1.1;endometrium 1: 1.0;lymphoid tissue: 1.7"	"Cell line enriched"	"Detected in single"	15	"THP-1: 5.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA058345	Uncertain									"HPA058345: AB_2683685"	"unprognostic (1.35e-1)"				"unprognostic (2.13e-3)"			"unprognostic (2.34e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.34e-1)"				"unprognostic (2.84e-2)"				0.0	0.0		0.0		0.0	0.0		0.0	0.2	0.0			0.0	1.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.1			0.0	0.0	0.0		0.0		0.0	0.3		0.0	0.3	0.0	0.3	0.0	0.0		1.7	0.0	0.3			0.0		0.5	0.0		0.4	0.7	0.2	0.2	0.3	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.0	0.1	1.1	0.4	0.8	0.5	0.4	0.4	0.5	1.0	0.2	0.3	0.1	0.7	0.3	0.3										
ADAMTS19		ENSG00000145808	"ADAM metallopeptidase with thrombospondin type 1 motif 19"	Q8TE59	5	129460265-129738683	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 16.6;endometrium 1: 14.6;smooth muscle: 9.0"	"Group enriched"	"Detected in some"	8	"MCF7: 11.7;SH-SY5Y: 27.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"olfactory region: 4.8"	"Low region specificity"	"Detected in all"			"HPA056171, HPA058438"	Uncertain		Approved	Vesicles,Midbody	"Secreted to extracellular matrix"			"Vesicles, Midbody"	"Vesicles, Midbody"	"HPA056171: AB_2683054, HPA058438: AB_2683718"	"unprognostic (1.14e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.49e-2)"		"unprognostic (3.93e-2)"		"unprognostic (4.17e-2)"	"unprognostic (5.99e-3)"	"unprognostic (5.17e-1)"		"unprognostic (1.14e-1)"	"unprognostic (5.88e-2)"		"unprognostic (3.06e-2)"	0.2	1.2	0.7	0.6	3.6	0.1	0.2	0.0	4.9	16.6	0.5	1.2	0.0	0.4	14.6	0.3	1.5	2.6	0.8	0.5	1.0	0.8	0.7	0.1	0.2	0.2	0.5	4.3	2.8	0.2	0.2	0.1	5.3	1.8	0.4	0.6	0.9	1.1	0.2	0.8	0.2	0.3	9.0	1.0	0.2	0.2	0.4	0.8	0.0	0.1	1.8	0.1	0.9	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	27.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.6	0.0	4.9	1.0	0.8	0.5	4.3	1.8	0.8
ADAMTSL1	"ADAMTSR1, C9orf94, FLJ35283"	ENSG00000178031	"ADAMTS like 1"	Q8N6G6	9	17906563-18910950	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 50.7;retina: 39.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 34.6;HSkMC: 17.6;hTEC/SVTERT24-B: 18.1;LHCN-M2: 17.8;TIME: 57.0;U-138 MG: 27.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057437, HPA074973"	Uncertain		Approved	Vesicles	"Secreted in other tissues"	74000000	74000000	Vesicles	Vesicles	"HPA057437: AB_2683440, HPA074973: "	"unprognostic (4.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.01e-4)"	"unprognostic (3.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.50e-2)"	6.3	7.6	0.5	5.9	0.8	0.0	4.4	3.9	1.5	14.3	5.2	0.6	6.5	1.6	50.7	12.0	9.0	5.2	4.4	2.9	1.6	1.0	3.4	1.0	1.9	2.2	0.4	1.2	4.9	1.3	0.1	3.9	0.8	0.9	8.4	4.6	39.3	3.1	5.6	0.5	2.0	2.7	13.3	0.7	0.9	5.0	2.3	0.0	0.0	2.0	1.7	1.5	2.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.3	0.0	5.0	34.6	0.0	1.0	4.4	4.1	9.3	0.0	0.0	0.0	0.0	12.1	0.0	1.8	0.2	12.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	17.6	0.0	18.1	0.0	7.6	0.0	0.0	17.8	0.0	0.0	0.0	1.6	0.1	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	27.8	0.7	0.7	4.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	3.9	1.5	1.6	1.0	0.4	1.2	0.9	0.0
AGTR2	"AT2, MRX88"	ENSG00000180772	"Angiotensin II receptor type 2"	P50052	X	116170722-116174972	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 20.8;lung: 26.7;smooth muscle: 13.6"	"Cell line enriched"	"Detected in single"	6	"HSkMC: 1.3"	"Group enriched"	"Detected in some"	12	"endometrial cancer: 3.0;lung cancer: 1.9"	"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"cerebellum: 3.8"															"unprognostic (2.13e-1)"				"unprognostic (1.71e-1)"			"unprognostic (3.22e-2)"				"unprognostic (4.37e-2)"			0.3	1.6	0.1	0.8	0.1	0.0	0.1	1.0	0.1	5.3	0.4	0.1	0.1	0.0	20.8	3.3	0.2	3.6	0.4	1.7	0.1	0.0	0.4	0.1	26.7	0.8	0.1	0.1	1.1	1.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	13.6	0.1	0.1	0.6	0.2	0.1	0.4	0.1	1.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ASPN	"FLJ20129, PLAP-1, SLRR1C"	ENSG00000106819	Asporin	Q9BXN1	9	92456205-92482506	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 62.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.4;BJ hTERT+: 4.9;HHSteC: 20.5;HSkMC: 4.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008435, HPA024230"	Approved				"Secreted to extracellular matrix"	33000	33000			"HPA008435: , HPA024230: "	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.13e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavourable (1.64e-7)"	"unprognostic (1.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.48e-2)"	13.4	2.2	0.5	5.2	1.7	0.0	4.8	0.4	0.7	40.2	14.6	0.6	8.1	2.8	62.1	26.7	15.3	9.9	26.4	31.6	0.6	0.6	3.5	21.9	10.3	0.7	0.9	1.4	7.8	4.7	0.8	1.9	3.7	1.0	12.2	3.6	1.6	2.0	3.6	10.8	3.7	19.7	37.1	0.8	0.8	8.8	6.7	0.4	1.5	7.1	27.7	2.2	24.2	3.8	0.4	0.2	1.9	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.3	14.4	0.0	1.9	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	4.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.2	0.1	0.7	0.2	0.0	0.0	0.5	1.7	0.4	0.7	0.6	0.6	0.9	1.4	1.0	0.4
ATP8B4	"ATPIM, KIAA1939"	ENSG00000104043	"ATPase phospholipid transporting 8B4 (putative)"	Q8TF62	15	49858238-50182817	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 18.6;NB-4: 7.1;THP-1: 12.0;U-937: 37.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 6.9;NK-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040254	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA040254: AB_10673028"	"unprognostic (6.45e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.08e-1)"	2.3	1.2	1.6	1.5	2.1	28.1	1.0	0.6	0.9	26.0	1.5	1.7	1.6	0.4	18.2	3.5	0.6	9.5	3.1	0.8	2.5	0.9	1.0	1.2	3.2	0.7	2.7	0.1	3.9	0.4	0.2	1.1	2.9	2.1	0.7	1.2	0.8	0.9	0.6	0.4	0.5	1.1	2.7	3.1	2.3	0.6	0.9	4.6	0.8	0.5	0.8	2.1	1.3	1.5	0.0	2.2	6.9	1.7	10.6	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.1	0.0	3.0	0.6	0.0	0.0	5.2	18.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	12.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.4	37.6	0.0	6.9	1.7	2.4	0.5	0.8	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.8	10.6	0.3	0.0	0.0	0.8	1.6	2.1	0.6	0.9	2.5	0.9	2.7	0.1	2.1	4.6
BNC2	"BSN2, FLJ20043"	ENSG00000173068	"Basonuclin 2"	Q6ZN30	9	16409503-16870843	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 35.8;ovary: 37.0"	"Cell line enhanced"	"Detected in many"		"HSkMC: 18.1;Karpas-707: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"gdTCR: 5.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 5.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA018525, HPA059419"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA018525: AB_1845402, HPA059419: AB_2732637"	"unprognostic (2.68e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.14e-3)"	4.3	1.0	0.5	5.1	0.7	0.3	4.3	0.5	0.7	19.8	7.6	1.8	2.9	0.8	35.8	5.5	3.8	14.3	9.3	3.8	1.2	0.5	7.6	0.4	2.6	0.9	0.9	0.5	37.0	0.5	2.7	1.5	2.2	2.3	6.4	2.1	11.0	1.3	4.8	7.6	2.9	2.8	23.1	2.0	0.5	3.0	4.7	1.0	0.9	1.7	3.6	1.3	8.5	9.0	0.1	0.0	0.0	0.0	1.0	5.8	3.2	0.1	0.9	0.7	0.0	9.9	12.2	1.5	6.1	10.8	4.4	3.6	0.0	0.0	0.0	2.0	4.2	0.0	2.9	0.0	4.5	0.1	1.1	0.1	2.9	0.0	7.6	0.0	0.2	18.1	0.0	9.3	0.0	9.8	0.0	22.1	6.2	0.0	0.0	1.5	3.6	5.6	0.0	6.9	14.8	3.3	0.2	0.1	0.5	0.0	0.0	10.5	0.0	0.0	9.6	10.4	7.6	8.3	11.2	0.1	0.0	0.0	4.2	1.3	1.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	1.0	0.0	0.0	0.0	3.2	0.5	0.7	0.5	0.7	1.2	0.5	0.9	0.5	2.3	1.0
CCDC80	"DRO1, SSG1, URB"	ENSG00000091986	"Coiled-coil domain containing 80"	Q76M96	3	112596794-112649530	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 130.0;endometrium 1: 143.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 64.4;ASC TERT1: 51.2;BJ: 42.5;fHDF/TERT166: 150.4;HSkMC: 50.5;LHCN-M2: 42.1;U-138 MG: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA002266	Approved				"Secreted to extracellular matrix"	57000	57000			"HPA002266: AB_1078423"	"unprognostic (1.26e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.99e-3)"	"unprognostic (8.40e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (2.86e-5)"	"unprognostic (5.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (1.26e-4)"	49.5	3.3	1.4	16.4	3.1	0.0	39.4	3.1	3.3	130.0	14.9	3.4	54.7	1.1	143.8	94.7	34.2	17.4	39.7	87.6	2.3	2.8	10.7	2.1	17.0	10.1	3.0	1.0	53.3	6.6	2.5	2.7	6.0	7.2	28.6	12.7	8.7	8.7	21.7	4.1	19.2	8.6	81.3	14.0	19.8	12.0	14.0	3.3	4.1	20.4	29.6	10.8	57.3	33.8	2.9	3.0	2.9	1.3	1.3	2.1	0.2	3.0	1.3	15.4	0.7	64.4	51.2	0.8	42.5	12.9	14.3	21.0	0.3	0.2	0.1	1.6	150.4	3.9	0.6	0.5	15.1	2.8	0.1	0.0	3.4	0.0	13.5	0.1	0.0	50.5	1.7	21.1	1.3	3.3	0.0	0.1	42.1	0.0	0.0	0.0	3.8	0.5	0.0	1.6	0.0	0.4	0.0	0.0	0.3	6.3	0.2	0.2	0.2	0.1	16.6	42.2	6.9	8.0	18.5	0.1	0.1	0.1	12.5	0.0	6.7	2.9	1.3	0.9	1.6	0.8	1.6	1.7	1.6	1.3	0.5	2.9	2.1	1.9	1.7	1.3	0.8	3.0	1.1	0.2	1.4	3.1	3.1	1.7	2.3	2.8	3.0	1.0	7.2	3.3
CHRDL2	BNF1	ENSG00000054938	"Chordin like 2"	Q6WN34	11	74696429-74731385	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 64.5;endometrium 1: 76.5;gallbladder: 109.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 6.0;PC-3: 3.1;SiHa: 6.0;TIME: 2.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 14.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA021771	Uncertain				"Secreted to extracellular matrix"	5600000	5600000			"HPA021771: AB_1846689"	"unprognostic (2.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (9.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.33e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.58e-6)"	"unprognostic (8.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (6.08e-4)"	1.0	0.0	0.0	39.3	0.2	0.0	1.7	0.1	0.3	64.5	27.9	0.1	1.0	1.4	76.5	47.6	4.3	2.9	109.2	35.8	0.1	0.1	1.0	14.5	0.8	0.5	0.0	0.0	6.7	1.0	0.4	0.1	1.5	0.4	8.0	0.9	0.9	0.2	3.5	2.6	0.3	3.5	45.3	0.6	0.8	24.1	7.6	0.0	0.1	0.2	3.2	1.1	22.6	8.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	6.0	0.7	0.0	1.2	0.0	0.7	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.9	3.1	0.0	0.5	0.0	0.0	0.0	0.1	0.2	6.0	0.0	0.1	0.0	0.0	2.1	0.0	0.2	0.0	0.5	0.4	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.0	0.0	0.4	0.0
COL3A1	EDS4A	ENSG00000168542	"Collagen type III alpha 1 chain"	P02461	2	188974320-189012746	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 304.2;endometrium 1: 208.0"	"Cell line enhanced"	"Detected in some"		"AF22: 80.2;ASC diff: 148.6;ASC TERT1: 258.7;fHDF/TERT166: 104.0;HHSteC: 102.2;HSkMC: 192.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA007583, CAB016766, CAB059993"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	16000000	16000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (3.59e-10)"	"unprognostic (1.70e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.17e-3)"	41.7	9.7	0.7	34.1	3.4	0.0	29.7	0.8	1.2	304.2	41.3	1.3	23.8	3.9	208.0	82.0	31.3	32.3	116.3	41.0	1.0	0.3	14.4	12.1	32.9	39.3	1.3	1.1	54.9	14.4	1.7	2.3	161.2	3.2	27.4	18.3	32.0	15.1	22.4	14.5	28.3	24.2	114.1	1.7	29.5	25.3	45.5	0.7	9.5	12.8	44.8	15.4	64.8	51.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.2	3.1	148.6	258.7	0.0	32.2	28.8	14.1	12.7	0.4	0.0	0.0	0.0	104.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	13.6	0.0	102.2	0.1	0.0	192.4	0.0	17.1	2.8	0.7	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.4	0.0	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	1.7	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.4	0.8	1.2	1.0	0.3	1.3	1.1	3.2	0.7
CRLF2	"CRL2, TSLPR"	ENSG00000205755	"Cytokine receptor like factor 2"	Q9HC73	X	1187549-1212750	"Cancer-related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 7.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 18.1;RPMI-8226: 4.6;U-698: 3.9"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	43	"plasmacytoid DC: 4.3"	"Lineage enriched"	"Detected in single"	43	"dendritic cells: 4.3"														"Intracellular and membrane"						"unprognostic (7.84e-2)"	"unprognostic (7.99e-4)"	"unprognostic (6.02e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.31e-6)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.88e-5)"	"unprognostic (7.09e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.62e-1)"	0.8	0.0	0.2	4.1	0.2	4.1	0.6	0.2	0.2	3.0	0.7	0.2	0.2	0.2	7.8	0.2	0.9	0.2	3.7	0.2	0.2	0.1	0.9	0.2	1.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	1.0	0.2	0.6	0.9	0.2	0.8	0.2	0.2	0.7	1.5	0.3	0.2	0.6	1.0	0.2	0.2	0.2	0.2	0.2	1.4	1.3	0.6	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.6	1.0	0.2	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.7	1.0	3.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
DCHS2	"CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ"	ENSG00000197410	"Dachsous cadherin-related 2"		4	154231742-154495570	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"endometrium 1: 8.6"	"Cell line enriched"	"Detected in some"	6	"U-2 OS: 7.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA064159	Uncertain		Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA064159: AB_2685201"	"unprognostic (1.38e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.27e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-3)"	0.9	1.6	3.4	1.3	7.0	1.1	1.0	0.6	4.8	2.6	4.0	1.9	1.1	1.3	8.6	1.5	1.0	2.0	1.6	0.8	3.5	2.6	0.9	0.7	1.1	0.8	3.0	2.3	1.9	0.6	1.1	1.7	0.8	4.6	1.6	1.5	2.7	0.8	3.6	1.0	2.1	1.0	3.0	7.0	0.8	4.9	2.6	2.9	0.0	1.0	0.0	0.9	2.3	1.2	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.4	7.0	0.6	4.8	3.5	2.6	3.0	2.3	4.6	2.9
DLX5		ENSG00000105880	"Distal-less homeobox 5"	P56178	7	97020392-97024950	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 17.7;placenta: 44.5;skin 1: 20.6"	"Group enriched"	"Detected in some"	5	"BEWO: 32.5;HAP1: 16.3"	"Cancer enriched"	"Detected in many"	11	"endometrial cancer: 81.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.5;olfactory region: 36.5"	"Region enhanced"	"Detected in many"		"olfactory region: 24.3"	HPA005670	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA005670: AB_1078681"	"unprognostic (3.99e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.43e-8)"	"unprognostic (1.39e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	1.5	0.6	2.7	0.5	11.5	0.3	1.5	0.1	3.9	10.0	0.6	0.3	1.4	0.7	17.7	1.7	5.8	2.0	0.8	1.2	2.2	4.5	0.4	0.2	0.4	1.9	0.5	2.5	2.1	0.2	0.4	1.9	44.5	0.0	1.8	0.3	0.1	3.6	3.9	0.6	20.6	0.3	1.4	0.2	0.3	0.3	1.2	3.1	2.5	1.6	6.5	2.7	1.5	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.7	16.3	0.0	0.0	0.0	2.7	0.0	0.3	0.2	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.1	0.9	1.3	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.0	0.0	1.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.5	0.1	3.9	2.2	4.5	0.5	2.5	0.0	3.1
DPP6	"DPL1, DPPX"	ENSG00000130226	"Dipeptidyl peptidase like 6"	P42658	7	153887097-154894285	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.7;endometrium 1: 24.5;thyroid gland: 24.1"	"Cell line enriched"	"Detected in some"	9	"NTERA-2: 11.0"	"Cancer enriched"	"Detected in some"	11	"glioma: 12.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050509	Enhanced	Supported								"HPA050509: AB_2681150"	"unprognostic (1.29e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.83e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.85e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.61e-3)"	"unprognostic (6.11e-2)"	1.6	7.2	15.4	1.4	32.5	1.3	1.5	26.6	45.7	2.3	6.8	8.7	0.0	1.6	24.5	3.1	1.5	4.6	1.3	1.4	26.6	15.2	3.6	1.2	2.2	1.3	14.0	22.7	1.3	4.0	1.2	4.9	1.3	18.8	1.5	2.4	0.4	1.3	8.1	4.6	3.7	2.0	15.8	7.2	4.2	3.5	7.9	10.0	0.0	24.1	0.0	1.2	1.3	0.4	0.6	0.6	1.9	0.9	0.9	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	11.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.9	0.4	0.7	0.4	0.6	0.7	0.6	0.6	0.4	0.4	0.6	0.7	0.7	1.6	0.9	0.9	0.6	0.5	0.3	15.4	32.5	26.6	32.4	26.6	15.2	14.0	22.7	18.8	10.0
ENTPD1	"ATPDase, CD39, NTPDase-1, SPG64"	ENSG00000138185	"Ectonucleoside triphosphate diphosphohydrolase 1"	P49961	10	95711779-95869695	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 59.4"	"Group enriched"	"Detected in some"	7	"HDLM-2: 56.0;Karpas-707: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 37.4"	"Low lineage specificity"	"Detected in many"											"CAB002494, HPA014067"	Enhanced		Uncertain	Microtubules				Microtubules	Microtubules	"CAB002494: AB_563557, HPA014067: AB_1848178"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.67e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (5.33e-5)"	"unprognostic (9.79e-2)"	"unprognostic (2.30e-1)"	"prognostic favourable (7.89e-4)"	"unprognostic (5.09e-2)"	10.4	7.5	7.4	16.2	8.4	15.6	8.8	7.6	6.9	18.9	12.7	13.1	8.7	5.8	59.4	12.8	13.2	15.6	22.2	6.8	7.4	7.4	6.2	3.9	14.8	14.5	8.5	4.9	10.3	2.8	3.0	4.3	24.0	9.9	14.7	9.1	10.8	6.7	12.7	3.3	5.5	12.2	37.2	17.9	25.3	7.5	5.4	7.2	3.5	13.4	12.5	21.1	25.2	12.4	6.0	11.8	37.4	15.2	0.5	5.1	4.6	0.1	0.3	0.9	0.8	0.0	0.0	0.5	0.5	0.4	0.0	0.0	0.5	0.1	1.0	0.6	0.0	0.2	0.0	0.0	0.0	56.0	0.7	0.6	0.4	0.7	0.0	1.5	0.2	0.0	0.0	0.2	0.0	7.4	0.6	46.0	0.0	0.6	0.4	1.5	0.6	0.2	2.3	0.3	0.7	0.5	0.2	0.7	1.0	0.3	1.1	0.7	0.5	1.6	0.8	0.4	0.2	0.6	0.6	6.6	0.9	0.0	0.6	3.1	0.2	0.1	15.2	37.4	0.1	10.7	0.3	6.0	0.6	0.3	11.8	4.6	0.1	0.1	26.7	0.5	2.4	0.7	5.1	4.6	7.4	8.4	7.6	6.9	7.4	7.4	8.5	4.9	9.9	7.2
EPO	EP	ENSG00000130427	Erythropoietin	P01588	7	100720800-100723700	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.9;endometrium 1: 8.7;liver: 29.3"	"Group enriched"	"Detected in some"	7	"BEWO: 3.5;Hep G2: 13.0"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.7;renal cancer: 5.4"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 4.4"	"Cell type enriched"	"Detected in single"	13	"non-classical monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			CAB010336	Supported				"Secreted to blood"					"CAB010336: AB_2098408"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavourable (5.67e-5)"	"unprognostic (3.52e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-1)"	"prognostic unfavourable (2.18e-6)"	"unprognostic (4.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.34e-1)"	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	4.4	10.9	0.0	0.0	0.0	0.0	8.7	0.6	0.4	0.0	0.0	0.1	0.0	0.0	2.8	29.3	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.7	0.0	1.6	0.0	0.7	0.9	1.6	0.0	0.7	0.0	0.6	0.0	0.0	0.0	2.4	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	1.1	0.1	0.0	0.0	13.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.6	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.2	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.4
ESR1	"ER-alpha, Era, ESR, NR3A1"	ENSG00000091831	"Estrogen receptor 1"	P03372	6	151656691-152129619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 64.5;endometrium 1: 68.9"	"Group enriched"	"Detected in some"	9	"MCF7: 24.3;T-47d: 31.5"	"Group enriched"	"Detected in many"	9	"breast cancer: 40.2;endometrial cancer: 24.3;ovarian cancer: 8.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB000037, HPA000449, HPA000450, CAB055099, CAB072858"	Enhanced		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754"	"unprognostic (8.28e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.43e-2)"	"prognostic favourable (5.47e-7)"	"unprognostic (4.79e-1)"	"unprognostic (2.43e-3)"	"unprognostic (4.10e-5)"	"unprognostic (9.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.91e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.52e-1)"	3.0	0.9	0.5	1.6	0.5	0.2	16.2	0.8	0.4	64.5	1.5	0.2	2.2	0.1	68.9	27.7	1.1	26.7	1.9	1.1	0.5	0.8	1.5	6.6	3.6	1.6	0.4	0.1	14.2	0.4	0.0	9.3	0.9	0.6	3.6	0.1	2.6	1.6	4.1	2.0	0.6	0.5	20.8	0.4	1.6	0.3	1.9	0.4	1.9	1.3	2.2	2.5	3.8	23.7	0.6	1.0	0.0	0.8	0.3	2.5	1.0	0.3	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.6	0.0	24.3	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.3	0.0	31.5	0.0	0.0	0.1	0.1	0.3	0.0	2.9	0.5	0.0	0.1	0.2	0.0	0.0	0.8	0.0	0.3	0.2	1.0	0.6	1.3	0.4	1.0	0.4	2.5	0.9	0.0	0.3	0.0	0.0	0.3	1.0	0.5	0.5	0.8	0.4	0.5	0.8	0.4	0.1	0.6	0.4
FAP	DPPIV	ENSG00000078098	"Fibroblast activation protein alpha"	Q12884	2	162170684-162245151	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 30.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 47.0;ASC TERT1: 49.9;BJ hTERT+: 39.4;TIME: 19.7;U-138 MG: 40.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059739	Uncertain				"Secreted to blood"	34000000	34000000			"HPA059739: AB_2684117"	"unprognostic (7.48e-3)"	"unprognostic (7.87e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (4.82e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.30e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.32e-11)"	"unprognostic (1.72e-3)"	"unprognostic (9.84e-3)"	"unprognostic (7.97e-2)"	"unprognostic (4.49e-3)"	19.8	0.7	2.6	3.2	1.2	0.0	7.5	0.6	3.7	17.6	4.5	0.4	4.0	0.1	30.0	13.7	4.1	5.1	14.9	5.2	3.1	0.9	2.0	0.9	4.7	0.8	2.6	1.2	4.1	2.3	0.5	1.0	17.0	1.9	4.1	1.5	2.4	5.3	3.9	8.1	2.9	1.4	17.9	2.2	0.9	1.7	9.8	3.4	0.0	3.5	9.0	0.8	12.4	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.0	49.9	0.0	19.2	39.4	4.0	6.1	0.0	0.0	0.0	0.1	7.3	0.0	0.0	1.2	1.9	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.0	16.1	0.3	6.7	1.2	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	2.0	0.0	0.0	19.7	40.1	0.8	9.7	0.0	0.0	0.0	0.0	9.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.2	0.6	3.7	3.1	0.9	2.6	1.2	1.9	3.4
FBXL22	"Fbl22, FLJ39626"	ENSG00000197361	"F-box and leucine rich repeat protein 22"	Q6P050	15	63597353-63602428	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 65.9;smooth muscle: 68.0"	"Cell line enhanced"	"Detected in many"		"MCF7: 7.9;SCLC-21H: 9.0;U-937: 5.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA047624, HPA054627"	Uncertain		Uncertain	Nucleoli,Cytosol				"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"HPA047624: AB_2680107, HPA054627: AB_2682548"	"unprognostic (2.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	1.9	0.4	0.4	5.5	0.4	0.0	1.1	0.6	0.7	31.4	26.0	0.0	20.8	1.4	65.9	7.6	11.9	10.5	31.1	10.3	0.4	0.4	0.6	0.4	0.7	0.2	0.4	0.3	7.1	0.4	0.0	0.4	1.0	0.2	20.1	2.9	1.9	3.3	24.0	2.2	0.7	4.1	68.0	0.4	0.4	6.3	4.2	0.0	0.0	0.6	1.0	0.4	38.2	4.8	1.5	4.3	0.5	0.2	2.0	2.9	0.5	1.2	2.1	0.3	1.3	0.7	0.9	0.1	0.4	0.1	0.5	0.0	1.4	1.6	0.5	1.1	0.2	1.3	0.7	0.4	0.0	1.3	0.9	0.4	1.5	3.5	0.2	0.5	0.2	0.5	0.3	0.1	0.7	0.2	0.0	1.9	0.0	7.9	1.2	1.0	2.5	0.8	1.1	0.0	3.8	0.3	0.4	9.0	0.3	1.0	1.8	0.3	3.2	0.9	1.3	0.6	1.7	0.8	0.4	1.2	2.0	1.3	0.9	5.6	1.3	0.4	0.1	0.0	1.2	0.1	1.6	1.5	1.3	1.4	0.0	1.2	2.9	1.0	0.5	2.0	0.2	4.3	0.1	0.5	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.3	0.2	0.0
FREM1	"C9orf143, C9orf145, C9orf154, DKFZp686M16108, FLJ25461, TILRR"	ENSG00000164946	"FRAS1 related extracellular matrix 1"	Q5H8C1	9	14734666-14910995	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 33.3;epididymis: 30.8"	"Cell line enriched"	"Detected in some"	8	"HEL: 62.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 22.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054897, HPA073351"	Enhanced				"Secreted to extracellular matrix"					"HPA054897: , HPA073351: "	"unprognostic (1.13e-5)"	"unprognostic (2.59e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.27e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.95e-13)"	"unprognostic (2.28e-3)"	"unprognostic (8.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.86e-1)"	4.4	2.5	1.5	3.2	1.4	0.2	4.0	22.2	2.5	10.9	7.5	5.0	22.9	1.8	33.3	30.8	0.9	4.5	3.1	7.3	1.8	2.0	10.4	0.8	2.6	0.1	1.1	1.0	2.3	14.2	6.0	1.2	4.6	4.0	3.1	1.5	5.0	1.0	11.4	0.7	2.6	9.3	12.8	2.7	0.4	1.3	3.5	0.6	1.7	0.8	3.4	1.1	2.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	22.2	2.5	1.8	2.0	1.1	1.0	4.0	0.6
GAS1		ENSG00000180447	"Growth arrest specific 1"	P54826	9	86944363-86947189	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 61.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.3;ASC diff: 13.3;BJ hTERT+: 26.2;HSkMC: 18.7;RH-30: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB024164, HPA036085, HPA066902"	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"CAB024164: AB_2107950, HPA036085: AB_2674932, HPA066902: "	"unprognostic (2.78e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (1.97e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (4.30e-2)"	"prognostic unfavourable (1.96e-5)"	"prognostic unfavourable (8.26e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavourable (1.13e-5)"	"unprognostic (3.59e-2)"	26.5	2.9	0.9	8.3	1.1	0.0	14.0	1.3	1.3	26.4	9.1	2.1	15.0	0.9	61.8	37.1	10.0	20.9	11.8	9.9	1.0	0.5	4.5	0.8	4.1	5.7	1.8	0.8	31.5	4.3	0.8	3.2	50.1	2.0	18.1	1.0	8.7	4.8	8.9	8.1	10.1	3.4	24.5	0.9	1.2	6.3	18.9	0.5	3.6	6.0	3.8	1.6	11.3	15.6	0.0	0.8	0.0	0.0	0.1	0.6	0.0	0.0	0.0	3.3	19.3	13.3	5.0	0.3	3.6	26.2	1.3	1.1	0.0	0.0	0.0	0.2	6.7	0.2	0.0	0.1	0.5	2.1	7.4	0.0	10.8	0.0	6.7	0.0	0.3	18.7	2.8	0.4	2.3	0.0	0.0	0.0	5.5	0.0	0.0	0.1	4.0	0.0	3.8	39.9	0.0	0.2	0.0	0.4	1.7	5.4	0.0	5.7	0.0	0.1	0.0	5.6	1.6	0.4	1.2	0.0	0.0	0.0	0.2	0.2	1.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.9	1.1	1.3	1.2	1.0	0.5	1.8	0.8	2.0	0.5
GLI3	"ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV"	ENSG00000106571	"GLI family zinc finger 3"	P10071	7	41960950-42237870	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.6"	"Cell line enhanced"	"Detected in many"		"AF22: 26.3;WM-115: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005534	Approved									"HPA005534: AB_1078973"	"unprognostic (2.53e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.48e-5)"	"unprognostic (9.13e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.00e-2)"	7.3	2.6	4.6	6.8	5.4	0.3	9.4	0.8	6.4	21.1	13.1	2.9	10.9	1.4	31.6	10.0	7.3	10.8	7.0	2.0	4.2	1.7	2.3	0.7	5.8	2.4	1.8	2.1	17.6	1.5	0.8	1.9	13.4	1.8	10.6	3.8	5.1	3.7	14.3	2.2	9.7	4.2	13.8	0.9	1.8	3.8	2.3	3.0	1.7	6.1	8.7	4.0	6.4	9.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	26.3	0.2	6.8	12.5	1.6	1.6	5.5	4.7	5.5	0.1	0.0	0.0	1.0	11.0	5.5	3.6	4.3	4.0	0.0	3.3	0.0	3.3	0.0	4.3	0.0	0.1	10.2	6.2	4.9	4.0	4.4	0.0	0.1	2.2	2.4	0.3	0.0	11.9	10.0	6.3	0.1	0.7	0.0	4.3	0.7	0.0	2.6	3.2	1.9	4.4	0.0	4.5	5.8	8.4	8.1	2.8	0.0	0.0	0.0	4.3	0.1	19.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.4	0.8	6.4	4.2	1.7	1.8	2.1	1.8	3.0
GLRA4		ENSG00000188828	"Glycine receptor alpha 4"	Q5JXX5	X	103707224-103728655	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 3.5;endometrium 1: 5.1;smooth muscle: 6.7"	"Cell line enriched"	"Detected in single"	13	"SCLC-21H: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA044759	Uncertain									"HPA044759: AB_10795885"	"unprognostic (4.96e-2)"		"unprognostic (2.09e-2)"		"unprognostic (3.95e-1)"	"unprognostic (2.24e-1)"			"unprognostic (1.28e-1)"		"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.94e-7)"	"unprognostic (4.49e-1)"	"unprognostic (1.94e-1)"		"unprognostic (1.87e-1)"	0.0	0.0	0.9	0.1	1.5	0.0	0.3	2.8	3.5	1.9	1.4	0.9	0.0	2.2	5.1	0.1	0.2	0.6	0.1	0.1	1.5	1.8	0.0	0.0	0.0	0.0	0.5	1.0	1.2	0.0	2.4	0.2	0.0	1.2	0.5	1.8	0.0	0.0	0.4	0.1	0.3	2.3	6.7	1.5	0.0	0.1	1.4	0.0	2.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	1.5	2.8	3.5	1.5	1.8	0.5	1.0	1.2	0.0
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 27.1;smooth muscle: 21.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"HPA015576: AB_1849283, HPA072047: AB_2686484"	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	2.4	0.9	2.1	3.6	1.7	0.0	1.9	1.2	4.0	7.3	4.9	3.1	8.5	0.8	27.1	8.2	7.4	7.7	5.6	2.4	2.8	1.5	1.1	0.4	2.8	0.4	3.0	1.2	7.6	11.0	4.9	1.3	1.3	3.0	8.2	2.3	3.4	2.3	9.4	0.8	1.5	2.1	21.0	3.0	1.2	2.2	3.0	0.8	1.4	1.2	1.7	0.7	2.8	6.8	0.3	1.2	1.5	0.5	0.2	0.3	0.2	6.1	3.8	15.3	9.8	3.7	6.6	0.0	5.9	6.4	5.0	5.4	23.8	1.0	0.0	3.3	8.8	18.2	3.7	5.8	2.9	2.3	4.7	2.2	3.0	0.1	1.5	0.6	1.5	2.3	3.7	4.3	7.0	10.1	2.0	0.1	7.6	0.5	0.7	0.1	6.3	6.0	1.8	6.6	0.0	2.6	1.6	3.1	13.5	6.4	0.2	17.6	3.4	0.7	13.5	10.5	5.4	14.0	6.6	0.0	0.0	0.0	2.8	0.0	2.6	1.5	0.3	0.2	0.1	0.3	0.1	0.1	0.1	0.0	1.2	0.3	0.1	0.3	1.3	0.2	0.5	0.3	0.0	0.2	2.1	1.7	1.2	4.0	2.8	1.5	3.0	1.2	3.0	0.8
GUCY1A2	"GC-SA2, GUC1A2"	ENSG00000152402	"Guanylate cyclase 1 soluble subunit alpha 2"	P33402	11	106674012-107018524	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 23.0;placenta: 23.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 12.2;BJ hTERT+ SV40 Large T+ RasG12V: 14.3;HBF TERT88: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009534	Uncertain									"CAB009534: AB_2279509"	"unprognostic (7.53e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.53e-3)"	"unprognostic (9.70e-3)"	"unprognostic (8.00e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (3.02e-5)"	"unprognostic (2.48e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.09e-2)"	5.5	3.3	4.6	1.3	10.9	0.6	3.9	4.3	10.7	19.2	1.5	1.2	1.1	0.9	23.0	5.0	1.3	8.4	2.6	3.8	4.6	4.0	3.2	2.8	11.8	1.6	3.7	5.3	3.9	6.2	1.8	1.5	23.6	5.5	3.2	1.3	1.4	1.4	10.1	4.1	1.4	1.2	18.0	2.4	7.9	1.0	2.8	5.4	0.0	2.4	3.0	1.0	2.2	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	4.3	0.0	0.2	2.6	2.3	0.3	12.2	1.6	14.3	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	7.6	0.0	1.2	0.0	0.1	0.0	0.2	0.0	1.7	0.7	0.0	1.9	0.2	0.9	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	3.7	0.0	0.8	0.8	0.2	4.7	3.9	3.2	0.8	1.3	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	10.9	4.3	9.9	4.6	4.0	3.7	5.3	5.5	5.4
HOXA10	"HOX1, HOX1H"	ENSG00000253293	"Homeobox A10"	P31260	7	27170591-27180261	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 48.2;endometrium 1: 45.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 54.8;THP-1: 28.8;U-937: 29.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 7.8;NK-cell: 12.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 7.8;NK-cells: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB019384	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"CAB019384: "	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-2)"	5.9	2.7	0.3	4.6	0.4	1.2	2.5	0.3	0.3	48.2	15.9	0.3	4.0	0.0	45.6	5.4	0.3	3.4	0.5	0.3	0.3	0.0	7.9	0.3	0.3	0.5	0.3	0.3	1.3	0.3	0.0	0.3	7.7	0.3	22.2	5.3	0.3	0.6	6.6	28.0	2.4	3.1	19.2	0.4	0.3	0.0	3.4	0.3	2.2	0.3	0.3	0.3	19.0	7.6	0.2	1.2	7.8	0.1	12.7	2.3	0.3	6.0	1.3	0.0	18.3	9.3	8.9	0.0	12.1	8.3	5.6	5.2	1.8	5.4	0.0	3.4	9.5	6.8	4.7	0.0	4.1	2.8	54.8	6.4	4.7	0.1	0.2	2.8	9.7	5.6	0.3	0.4	0.0	8.4	0.2	0.0	4.0	0.0	0.0	18.6	0.0	5.7	0.5	1.2	0.0	10.7	2.9	14.5	0.0	4.2	0.0	0.0	0.0	28.8	0.0	0.0	5.0	6.5	0.0	0.1	0.0	0.0	0.0	29.9	0.1	7.8	0.1	0.3	2.3	0.0	0.0	0.1	0.0	0.2	1.2	0.2	0.0	0.0	0.0	12.7	0.0	0.4	0.0	0.3	0.3	0.4	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
HOXA11	"HOX1, HOX1I"	ENSG00000005073	"Homeobox A11"	P31270	7	27181510-27185223	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 35.7;endometrium 1: 60.9;smooth muscle: 27.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.5;HEK 293: 24.6;THP-1: 17.6;U-937: 22.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006770, HPA035623"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA006770: AB_2667672, HPA035623: AB_10601576"	"unprognostic (5.95e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.29e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.82e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (2.57e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.56e-1)"	1.5	0.4	0.0	1.7	0.0	0.0	2.0	0.0	0.0	35.7	9.3	0.0	5.7	0.0	60.9	8.8	0.0	0.7	0.0	0.2	0.0	0.0	3.6	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	9.0	0.0	16.5	2.4	0.0	0.1	6.3	4.9	0.7	0.2	27.3	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	20.1	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.1	0.0	6.7	8.2	5.8	0.0	14.5	17.5	10.3	7.4	0.1	0.8	0.0	3.3	12.2	1.6	8.6	0.0	7.5	0.8	24.6	3.0	6.0	0.3	0.5	6.1	0.8	3.7	0.3	0.0	0.0	7.4	0.1	0.0	1.1	0.1	0.0	4.7	0.0	7.2	0.3	0.0	0.1	4.9	4.2	3.2	0.0	3.5	0.0	1.0	0.6	17.6	0.0	0.1	7.1	1.6	0.7	0.0	0.0	0.0	0.1	22.9	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXD10	"HOX4, HOX4D"	ENSG00000128710	"Homeobox D10"	P28358	2	176108790-176119942	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 21.7;endometrium 1: 38.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.1;HEK 293: 25.4;RPTEC TERT1: 18.2;SCLC-21H: 7.1;SiHa: 10.6;U-251 MG: 8.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065871			Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"				Nucleoplasm	Nucleoplasm	"HPA065871: AB_2685573"	"unprognostic (4.29e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (1.92e-6)"	"unprognostic (2.15e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.27e-1)"	0.9	0.0	0.1	1.2	0.1	0.0	21.7	0.1	0.1	10.3	9.5	0.1	1.4	0.0	38.2	2.8	1.2	1.6	0.6	0.6	0.1	0.0	16.3	0.1	0.8	0.2	0.1	0.1	2.7	0.1	0.0	0.1	3.0	0.1	9.5	4.3	0.1	0.5	5.1	0.2	1.0	0.1	14.2	0.1	0.1	0.0	3.9	0.1	0.2	0.3	0.4	1.4	2.1	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.3	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	18.2	0.0	7.1	1.9	10.6	0.0	0.0	0.0	0.0	1.6	0.0	1.3	0.5	8.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
HOXD11	"HOX4, HOX4F"	ENSG00000128713	"Homeobox D11"	P31277	2	176104216-176109754	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 15.8"	"Cell line enhanced"	"Detected in some"		"HEK 293: 20.3;SCLC-21H: 6.2;U-251 MG: 4.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055155			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA055155: AB_2682719"	"unprognostic (1.99e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.48e-1)"		"unprognostic (1.93e-2)"	"unprognostic (2.13e-2)"	"unprognostic (6.73e-2)"		"unprognostic (5.00e-2)"	"unprognostic (2.11e-8)"	"unprognostic (2.09e-3)"	"unprognostic (2.49e-2)"		"unprognostic (2.27e-3)"	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	5.4	4.2	0.0	0.0	0.0	15.8	0.4	0.3	0.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.6	0.3	5.7	0.9	0.0	0.0	2.9	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	1.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.1	0.0	20.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.3	6.2	0.3	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0
HOXD3	"HOX1D, HOX4, HOX4A"	ENSG00000128652	"Homeobox D3"	P31249	2	176136612-176173102	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 25.9;epididymis: 36.4;seminal vesicle: 22.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 7.9;HSkMC: 9.3;RPTEC TERT1: 9.7;SCLC-21H: 13.8;SH-SY5Y: 9.3"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	36	"pons and medulla: 3.8"	"Region enriched"	"Detected in single"	30	"pons and medulla: 6.7"	"HPA051831, HPA063671"			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA051831: , HPA063671: AB_2685083"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.56e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.47e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.44e-2)"	6.2	1.1	0.4	3.2	0.4	0.2	19.6	0.2	0.2	8.7	3.6	0.0	22.5	0.3	25.9	36.4	1.1	4.8	2.0	0.4	0.8	0.5	8.5	0.2	0.3	0.8	1.5	0.0	7.0	0.3	0.2	0.2	0.2	0.5	2.1	0.4	0.0	0.6	22.6	0.7	0.7	0.4	4.0	7.2	1.9	0.3	3.6	0.0	0.0	0.4	0.2	0.3	1.7	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.9	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	9.3	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	9.7	0.5	13.8	9.3	0.1	0.1	3.9	0.0	0.0	0.6	0.0	0.2	0.7	0.4	0.0	0.1	0.0	0.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.8	0.5	1.5	0.0	0.5	0.0
HOXD9	"HOX4, HOX4C"	ENSG00000128709	"Homeobox D9"	P28356	2	176122720-176124937	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 26.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 8.6;HEK 293: 12.0;RPTEC TERT1: 14.1;SH-SY5Y: 16.4;SK-MEL-30: 9.0;TIME: 12.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068683			Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA068683: AB_2686018"	"unprognostic (1.89e-1)"	"unprognostic (9.41e-2)"	"prognostic unfavourable (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-2)"	"prognostic favourable (9.58e-4)"	"prognostic unfavourable (1.08e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.56e-3)"	"unprognostic (6.71e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.38e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.44e-2)"	4.1	2.7	0.2	1.7	0.4	0.0	11.4	0.2	0.2	13.1	10.8	0.2	10.4	0.0	26.2	12.0	1.6	5.1	2.6	0.5	0.2	0.0	19.7	0.2	0.7	2.4	0.2	0.2	8.9	0.2	0.0	0.2	1.6	0.4	13.0	2.2	0.2	0.4	16.0	3.8	3.9	1.1	12.6	0.6	3.7	0.1	9.8	0.2	0.3	2.2	2.2	1.3	2.4	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	1.2	0.8	1.0	0.8	0.0	0.0	0.0	8.6	1.1	5.6	0.0	0.0	0.6	0.0	12.0	0.0	0.6	0.0	0.1	0.0	0.0	2.8	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	14.1	5.2	3.2	16.4	4.1	0.0	9.0	0.0	0.0	12.4	0.0	2.8	4.0	4.3	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2
IL17C	"CX2, IL-17C, IL-21, MGC126884, MGC138401"	ENSG00000124391	"Interleukin 17C"	Q9P0M4	16	88638591-88640473	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"endometrium 1: 7.6"	"Cell line enhanced"	"Detected in some"		"MCF7: 3.6;RPMI-8226: 1.6;SCLC-21H: 2.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065051	Supported				"Secreted to blood"					"HPA065051: AB_2685413"	"unprognostic (1.60e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.45e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.93e-2)"		"unprognostic (3.50e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.73e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.56e-3)"	"unprognostic (8.37e-3)"	0.1	0.0	0.1	0.1	0.6	0.8	0.1	1.2	0.1	1.0	0.1	0.1	0.1	0.0	7.6	0.1	0.8	0.2	1.4	2.3	0.1	0.0	0.1	0.1	3.6	0.2	0.1	0.1	0.1	0.1	0.2	0.3	1.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.9	0.5	0.1	0.1	1.3	0.9	2.0	0.1	0.1	0.1	2.5	0.1	1.2	0.1	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.6	0.0	0.2	0.0	0.0	0.2	0.0	1.6	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	1.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ITGA11	HsT18964	ENSG00000137809	"Integrin subunit alpha 11"	Q9UKX5	15	68296533-68432162	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 41.9;endometrium 1: 59.6;smooth muscle: 30.2"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 66.9;U-138 MG: 46.5;WM-115: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"basal ganglia: 6.1"	HPA051813	Uncertain					42000	42000			"HPA051813: AB_2681622"	"unprognostic (4.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.63e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.36e-1)"	"prognostic unfavourable (3.22e-7)"	"unprognostic (8.38e-3)"	"unprognostic (2.28e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.33e-2)"	4.5	2.9	0.4	3.5	0.9	0.0	2.9	0.5	3.6	41.9	1.5	0.9	3.5	0.6	59.6	11.4	2.6	8.0	3.4	9.0	0.5	0.5	4.9	0.7	1.3	0.5	0.8	0.5	15.7	0.8	0.2	1.5	2.2	1.3	4.5	1.4	1.5	0.9	8.9	1.9	2.1	1.6	30.2	0.9	4.0	1.3	3.4	0.7	0.2	1.8	5.8	0.7	5.6	7.4	1.7	1.3	1.8	1.0	0.8	1.5	0.1	0.0	0.0	0.1	0.2	2.2	0.0	0.0	4.4	8.6	1.0	0.3	0.0	0.0	0.0	0.3	66.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1	3.6	0.0	5.9	0.0	3.7	0.8	0.0	1.9	0.1	0.0	0.0	0.0	11.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.1	2.7	46.5	0.3	0.9	0.0	0.0	0.0	0.0	6.9	0.0	25.8	1.6	1.0	0.9	1.2	0.9	1.5	0.8	1.1	1.0	0.7	1.7	1.3	1.2	1.8	0.8	0.8	1.3	1.0	0.1	0.4	0.9	0.5	3.6	0.5	0.5	0.8	0.5	1.3	0.7
KCNAB3	"AKR6A9, KCNA3B"	ENSG00000170049	"Potassium voltage-gated channel subfamily A regulatory beta subunit 3"	O43448	17	7921859-7929803	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 36.1;endometrium 1: 17.2"	"Cell line enhanced"	"Detected in many"		"REH: 14.9;SH-SY5Y: 8.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"cerebellum: 36.1;cerebral cortex: 31.6"	"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.5;plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077993			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA077993: AB_2686872"	"unprognostic (3.02e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.84e-4)"	"unprognostic (2.19e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.55e-2)"	"unprognostic (3.27e-4)"	"unprognostic (7.47e-3)"	"unprognostic (3.03e-6)"	"unprognostic (2.12e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.97e-2)"	"unprognostic (9.54e-3)"	1.4	0.7	4.2	2.7	5.2	5.5	1.2	36.1	31.6	1.8	1.4	0.8	0.0	1.3	17.2	2.2	0.8	3.5	2.1	0.7	4.7	2.9	1.7	1.1	1.5	3.8	2.4	6.3	2.1	1.0	0.8	4.9	1.6	5.9	2.3	2.0	3.8	1.3	1.4	1.0	3.3	1.9	11.4	5.2	2.6	2.2	1.7	1.9	0.8	1.6	0.0	3.3	1.0	1.0	0.1	1.7	0.5	0.2	0.0	0.7	0.1	1.3	1.1	5.5	1.4	0.6	1.4	1.9	4.9	3.1	4.2	4.8	0.7	0.3	2.2	0.3	0.8	0.4	1.5	0.7	6.0	1.8	2.3	0.7	0.9	0.0	5.1	0.2	3.0	2.1	1.6	4.5	0.2	0.3	0.5	0.3	0.7	1.0	0.8	2.6	0.8	0.7	14.9	1.5	0.6	0.5	1.7	0.3	8.0	0.4	0.0	0.9	1.4	0.1	0.3	0.7	2.8	1.1	0.4	1.1	1.2	1.2	2.1	2.9	1.0	0.0	0.2	0.0	0.5	0.0	0.7	0.0	0.0	0.0	1.5	0.1	0.2	0.2	0.5	0.0	0.0	1.7	0.0	0.1	4.2	5.2	36.1	31.6	4.7	2.9	2.4	6.3	5.9	1.9
KCNG1	"K13, KCNG, kH2, Kv6.1"	ENSG00000026559	"Potassium voltage-gated channel modifier subfamily G member 1"	Q9UIX4	20	51003656-51023129	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 25.8;endometrium 1: 48.3"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 26.3;U-138 MG: 20.0;WM-115: 16.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	27	"naive B-cell: 10.8"	"Lineage enriched"	"Detected in single"	87	"B-cells: 10.8"	"Group enriched"	"Detected in many"	5	"amygdala: 21.4;basal ganglia: 17.0;cerebral cortex: 15.2;hippocampal formation: 19.7"	"Group enriched"	"Detected in all"	4	"amygdala: 16.3;basal ganglia: 12.0;cerebral cortex: 22.5;hippocampal formation: 21.1"	"HPA039530, HPA040024"	Approved		Approved	Vesicles				Vesicles	Vesicles	"HPA039530: AB_10795144, HPA040024: AB_10796338"	"unprognostic (1.19e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.05e-4)"	"unprognostic (2.53e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.83e-9)"	"unprognostic (1.52e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-2)"	0.5	4.5	13.3	2.9	7.0	0.3	0.7	2.3	11.9	9.6	2.4	1.6	25.8	0.6	48.3	2.8	3.7	11.9	1.9	1.0	7.9	2.9	0.5	0.4	0.5	3.0	2.0	9.5	0.9	3.7	1.3	0.8	9.3	6.7	5.6	1.3	0.7	1.4	18.3	0.3	0.5	7.2	5.8	1.0	3.5	0.8	5.4	2.6	0.0	0.5	0.0	1.4	2.8	3.4	10.8	0.0	0.0	0.1	0.0	0.0	0.1	0.4	1.7	1.3	6.4	0.7	1.7	0.1	5.6	0.0	3.3	2.6	0.1	0.1	0.0	3.5	1.6	1.6	0.8	1.6	3.4	0.2	2.1	0.0	6.2	0.0	11.7	0.0	0.2	3.4	26.3	12.6	12.9	0.8	0.1	0.0	0.3	6.3	0.0	0.1	6.7	11.6	0.0	0.0	0.0	0.0	1.9	1.9	7.3	12.2	14.3	9.2	1.0	0.9	0.3	20.0	11.8	0.1	1.6	0.0	0.0	0.0	5.9	0.4	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	13.3	7.0	2.3	11.9	7.9	2.9	2.0	9.5	6.7	2.6
KIR2DL1	"47.11, CD158A, cl-42, nkat1, p58.1"	ENSG00000125498	"Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1"	P43626	19	54769811-54784322	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.8;lung: 4.0;lymphoid tissue: 4.5"	"Cell line enriched"	"Detected in single"	25	"U-266/84: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.4"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.4"																				"unprognostic (2.14e-1)"	"unprognostic (9.82e-2)"		"unprognostic (8.18e-2)"		"unprognostic (2.19e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.19e-4)"	"unprognostic (4.11e-2)"	"unprognostic (6.87e-2)"		"unprognostic (1.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.61e-2)"		0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.1	0.1	0.0	0.0	0.1	2.8	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	2.2	4.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	1.8	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.8	4.5	0.4	1.4	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0
KLHL13	"BKLHD2, FLJ10262, KIAA1309"	ENSG00000003096	"Kelch like family member 13"	Q9P2N7	X	117897813-118117340	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 35.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 22.2;RH-30: 13.9;RPTEC TERT1: 39.9;SH-SY5Y: 35.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;eosinophil: 9.3;plasmacytoid DC: 5.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.6;granulocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA046039: AB_2679514, HPA059901: AB_2684155"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.31e-1)"	2.4	5.5	3.4	3.9	11.9	0.2	19.0	2.5	3.7	24.9	5.3	3.1	6.6	2.2	35.6	5.6	5.4	8.1	10.1	9.0	2.3	4.0	15.4	3.3	1.4	0.4	4.7	2.1	7.7	3.3	3.5	5.0	1.7	6.6	7.3	3.0	5.6	2.6	9.7	2.3	1.5	4.9	22.2	3.5	1.1	3.5	2.8	4.9	3.6	1.4	3.1	1.2	8.2	5.0	0.0	5.6	9.3	0.1	1.4	0.9	0.4	0.4	0.1	2.6	5.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	3.3	0.0	0.0	6.2	0.0	6.2	12.5	2.0	0.0	0.0	4.8	0.1	22.2	0.0	0.3	0.4	0.8	0.6	0.9	0.0	0.2	9.5	0.0	0.0	0.0	0.5	2.1	0.5	5.0	3.5	0.0	13.9	0.0	39.9	1.4	0.0	35.6	0.1	0.4	0.3	7.7	0.0	0.2	0.9	1.1	0.7	3.1	0.1	0.0	0.0	3.8	0.0	1.5	3.2	0.1	9.3	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.9	0.8	0.0	1.4	0.0	5.6	0.4	0.4	3.4	11.9	2.5	3.5	2.3	4.0	4.7	2.1	6.6	4.9
LIMS3		ENSG00000256977	"LIM zinc finger domain containing 3"	P0CW19	2	109898428-109924868	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 11.9;endometrium 1: 9.7"	"Cell line enhanced"	"Detected in many"		"HEL: 9.6;HMC-1: 29.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.9"	"Low lineage specificity"	"Detected in many"											HPA058455	Uncertain		Approved	"Focal adhesion sites,Cytosol"				Cytosol	Cytosol	"HPA058455: AB_2683723"										"unprognostic (2.23e-2)"								1.2	2.8	0.5	2.2	0.5	0.0	1.0	0.8	0.5	1.0	0.7	0.3	4.2	0.2	9.7	2.8	1.2	7.1	0.9	2.6	0.5	0.5	2.6	0.6	0.8	2.8	0.6	0.3	2.2	0.7	0.3	2.4	5.6	0.3	1.0	0.8	0.6	2.2	0.6	3.0	0.8	0.5	1.2	0.6	0.6	0.7	3.7	0.3	0.3	1.0	0.3	0.3	2.6	0.7	0.7	2.5	11.9	5.5	1.1	6.2	8.0	0.0	0.1	1.2	1.5	0.5	0.4	0.0	1.5	0.0	0.2	0.6	1.5	0.0	0.0	4.6	0.3	0.8	0.0	1.8	1.3	2.3	0.0	9.6	0.4	0.9	1.4	1.7	29.2	2.1	1.1	1.1	1.3	2.4	2.0	1.6	3.2	0.1	0.0	0.2	1.5	0.5	1.7	3.1	1.0	0.8	1.5	0.4	3.5	3.9	0.0	0.7	0.0	0.5	7.1	6.3	5.8	3.2	0.3	0.0	0.0	1.8	0.8	0.0	1.9	4.7	3.3	11.9	0.9	5.5	1.5	0.7	5.0	1.7	2.5	0.2	0.9	0.3	0.7	1.1	5.2	0.2	6.2	8.0	0.5	0.5	0.8	0.5	0.5	0.5	0.6	0.3	0.3	0.3
LINGO2	"LERN3, LRRN6C"	ENSG00000174482	"Leucine rich repeat and Ig domain containing 2"	Q7L985	9	27948078-28670286	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 10.5;smooth muscle: 11.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;hTERT-HME1: 2.3;SH-SY5Y: 13.4;U-87 MG: 2.3;WM-115: 5.9"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	8	"NK-cell: 3.4"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA016633, CAB025361"	Approved									"CAB025361: , HPA016633: AB_1853362"	"unprognostic (1.27e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-4)"	"unprognostic (9.86e-4)"	"unprognostic (7.55e-3)"		"unprognostic (2.67e-6)"	"unprognostic (1.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.74e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.95e-4)"	0.0	0.3	1.8	0.0	1.7	0.0	0.0	1.0	3.4	0.3	0.0			0.0	10.5	1.0	0.0	0.4	1.0	0.0	1.4	4.1	0.6	0.0	0.0	0.0	0.6		0.0	0.0	2.7	0.6	1.8		0.6	0.0		0.0	1.9	0.0	0.0	0.0	11.4	0.3	0.0	0.4	1.8			3.7		0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.4	0.4	1.7	0.0	0.5	0.3	3.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	1.1	0.3	2.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	13.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.3	0.0	5.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	1.7										
MEIS3	"DKFZp547H236, MRG2"	ENSG00000105419	"Meis homeobox 3"	Q99687	19	47403124-47419523	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 35.3;endometrium 1: 28.8"	"Cell line enhanced"	"Detected in many"		"AF22: 27.9;HMC-1: 24.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046699	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA046699: AB_2616456"	"unprognostic (3.27e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.49e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.76e-2)"	"prognostic unfavourable (1.78e-6)"	"unprognostic (9.29e-3)"	"unprognostic (9.21e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.80e-3)"	5.6	3.9	35.3	4.7	10.6	0.0	5.0	11.0	25.3	8.4	4.7	2.4	3.8	3.5	28.8	2.2	6.0	14.2	6.0	3.7	23.2	11.6	1.5	1.1	3.1	1.2	2.6	14.6	7.4	1.7	1.1	4.9	7.4	3.8	7.0	2.1	4.1	3.6	6.4	1.4	1.6	3.8	22.5	1.7	2.4	2.6	3.3	2.0	0.5	3.4	1.6	1.4	6.1	4.7	0.0	0.2	0.5	0.7	0.0	0.1	0.4	0.3	11.9	27.9	0.1	15.2	13.1	0.4	12.4	19.1	9.7	17.2	1.0	1.9	0.0	1.4	20.4	1.4	2.9	3.4	3.3	18.6	4.2	0.0	4.3	0.1	9.8	0.2	24.2	9.6	0.7	3.8	2.0	0.0	0.2	2.8	1.1	11.3	0.0	0.1	8.1	0.7	0.0	2.0	0.3	0.6	0.8	1.1	22.6	10.7	0.9	5.1	0.6	3.5	0.0	7.5	18.9	5.4	1.6	0.0	0.0	0.0	20.9	1.1	14.9	0.1	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.4	35.3	10.6	11.0	25.3	23.2	11.6	2.6	14.6	3.8	2.0
MEX3A	"RKHD4, RNF162"	ENSG00000254726	"Mex-3 RNA binding family member A"	A1L020	1	156072013-156081998	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 7.2;ovary: 10.1"	"Cell line enhanced"	"Detected in many"		"AF22: 25.0;NTERA-2: 22.7;SCLC-21H: 23.6;SH-SY5Y: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062703			Supported	Cytosol				Cytosol	Cytosol	"HPA062703: AB_2684840"	"unprognostic (8.63e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.55e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavourable (9.23e-8)"	"unprognostic (4.25e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.73e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.96e-2)"	0.4	0.2	1.8	1.0	1.8	0.8	2.5	3.3	5.1	2.5	1.3	1.4	0.2	0.7	7.2	0.7	1.4	1.7	1.1	0.2	3.5	1.0	1.1	1.8	0.6	3.4	1.9	2.1	10.1	0.6	0.4	0.4	0.8	2.2	1.7	1.0	1.0	2.0	0.6	0.2	0.7	0.6	1.7	1.0	1.4	0.5	3.1	2.0	3.6	1.5	0.2	1.1	1.9	1.4	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.7	25.0	6.2	0.3	0.4	2.9	0.6	0.1	1.0	0.9	1.4	0.3	0.7	2.9	0.3	0.5	10.8	0.4	1.2	1.2	2.9	0.6	1.1	2.4	0.5	0.3	0.5	0.7	0.8	0.5	0.4	4.7	5.6	0.0	1.4	1.6	2.8	0.4	22.7	3.2	9.2	2.0	0.1	0.8	1.1	23.6	43.1	0.7	2.8	1.4	4.8	1.8	1.6	1.5	3.9	0.4	1.4	0.5	0.4	1.3	0.1	0.7	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	3.3	2.0	3.5	1.0	1.9	2.1	2.2	2.0
MINDY4B	"C3orf76, FAM188B2"	ENSG00000214237	"MINDY family member 4B"		3	150871045-150905439	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 7.5;endometrium 1: 2.8"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;T-47d: 3.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.3"	"Low region specificity"	"Detected in single"																		"unprognostic (1.91e-4)"	"unprognostic (6.32e-3)"	"unprognostic (6.09e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.07e-3)"		"unprognostic (3.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.77e-1)"	"unprognostic (2.16e-1)"	0.0	0.9	0.0	0.0	7.5	0.2	0.0	0.0	0.6	0.0	0.0			0.2	2.8	0.0	0.4	0.7	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.1		0.4	0.0	0.0	0.0	0.4		0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9			0.0		0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0										
MOXD1	"dJ248E1.1, DKFZP564G202, MOX"	ENSG00000079931	"Monooxygenase DBH like 1"	Q6UVY6	6	132296055-132401545	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 57.2;smooth muscle: 41.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 37.6;ASC TERT1: 30.3;BJ: 22.9;fHDF/TERT166: 42.6;HBF TERT88: 27.5;U-2197: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	47	"memory B-cell: 4.9;naive B-cell: 2.8;plasmacytoid DC: 7.8"	"Group enriched"	"Detected in many"	58	"B-cells: 4.9;dendritic cells: 7.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035740	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA035740: AB_10610141"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.87e-3)"	"unprognostic (5.62e-2)"	"prognostic favourable (7.09e-5)"	"unprognostic (5.77e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavourable (3.72e-4)"	"unprognostic (2.92e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.73e-2)"	1.9	19.5	13.4	3.8	12.5	0.2	1.4	0.3	16.0	17.2	7.7	6.7	7.3	2.7	57.2	7.8	17.4	1.9	15.1	3.2	9.8	1.1	21.4	1.2	15.3	2.9	1.0	6.4	2.4	1.7	0.1	4.3	3.3	0.2	17.6	4.9	0.9	10.6	21.5	0.4	7.4	4.5	41.1	0.8	3.2	3.1	3.1	4.6	0.8	1.5	7.7	7.7	9.4	8.6	4.9	7.8	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.9	0.0	37.6	30.3	0.0	22.9	15.6	8.4	14.7	0.0	0.2	0.1	0.0	42.6	0.0	0.3	0.1	27.5	0.0	4.2	0.0	0.0	0.0	0.3	0.0	0.0	7.2	0.0	16.9	0.5	0.0	0.0	1.7	4.9	0.0	0.0	0.0	0.7	0.1	0.2	0.1	0.0	10.3	0.0	0.6	0.0	0.0	0.1	0.5	0.0	1.2	0.1	3.9	3.6	68.2	11.9	0.9	0.0	0.0	9.7	0.0	11.2	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.3	13.4	12.5	0.3	16.0	9.8	1.1	1.0	6.4	0.2	4.6
OSR2	FLJ90037	ENSG00000164920	"Odd-skipped related transciption factor 2"	Q8N2R0	8	98944403-98952104	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 47.9"	"Cell line enriched"	"Detected in some"	17	"ASC diff: 111.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052425, HPA063486"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA052425: AB_2681826, HPA063486: AB_2685022"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.57e-1)"	"prognostic favourable (2.44e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.73e-3)"	"unprognostic (3.01e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.57e-7)"	"unprognostic (1.37e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.54e-3)"	10.6	2.4	0.5	4.2	0.7	0.0	10.9	0.6	0.5	41.7	3.1	0.5	10.2	0.0	47.9	18.9	4.6	37.6	7.3	1.9	0.5	0.0	1.3	0.5	1.3	2.0	0.8	0.5	36.3	1.4	0.6	1.0	7.7	0.7	20.9	0.8	0.5	1.4	23.7	3.5	6.7	7.4	15.3	0.8	0.5	1.3	27.0	0.6	0.8	1.8	1.8	3.0	6.7	24.1	0.0	0.0	1.0	0.0	0.0	0.6	0.6	6.1	0.8	0.0	0.8	111.2	3.5	0.8	3.4	6.6	2.7	2.7	0.6	0.7	0.0	0.5	5.2	2.4	0.5	0.9	1.3	0.2	2.5	0.1	0.6	0.3	1.8	0.1	0.1	3.5	1.9	0.4	0.3	0.0	0.7	0.0	0.1	2.8	0.5	1.0	0.0	0.5	2.6	0.3	0.2	0.2	0.5	0.2	0.0	0.3	1.4	0.0	0.8	1.4	0.0	0.4	0.0	2.7	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.7	0.6	0.5	0.5	0.0	0.8	0.5	0.7	0.6
PPP1R12B	"MGC131980, MGC87886, MYPT2, PP1bp55"	ENSG00000077157	"Protein phosphatase 1 regulatory subunit 12B"	O60237	1	202348699-202592706	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 105.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 15.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024171, HPA024640"	Enhanced		Approved	"Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"	"Plasma membrane, Actin filaments"	"HPA024171: AB_1854266, HPA024640: AB_1854265"	"unprognostic (5.24e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.60e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	10.6	2.8	6.9	8.1	9.0	1.8	7.7	13.9	10.5	55.3	62.0	15.0	31.0	5.8	105.2	9.4	37.4	21.9	17.4	83.1	5.8	4.5	5.0	2.9	8.1	4.2	10.1	9.2	18.7	2.3	2.0	4.5	8.4	9.5	36.4	16.3	13.7	5.7	50.3	17.6	5.3	14.1	59.5	7.3	6.9	20.8	3.4	11.1	1.3	5.0	11.2	3.5	35.1	11.4	2.3	1.7	15.9	1.8	0.7	1.7	0.5	2.7	5.4	4.2	3.9	5.9	4.3	6.8	2.1	2.2	2.2	2.1	2.3	4.8	3.0	1.1	3.9	8.6	6.2	3.3	2.4	3.9	3.8	3.0	7.9	1.5	1.4	6.5	3.5	3.4	3.8	3.2	3.3	1.8	4.5	3.6	3.9	2.0	4.8	4.1	2.8	1.1	3.2	10.7	4.4	1.8	9.8	5.1	3.9	4.1	4.9	2.4	4.3	3.0	2.3	3.2	1.9	2.3	1.8	5.3	5.0	3.3	3.0	5.3	12.6	1.8	1.8	1.3	1.7	0.9	1.4	1.7	1.1	1.0	1.4	2.3	1.4	1.0	15.9	0.7	1.4	1.7	1.6	0.5	6.9	9.0	13.9	10.5	5.8	4.5	10.1	9.2	9.5	11.1
PTGER3	EP3	ENSG00000050628	"Prostaglandin E receptor 3"	P43115	1	70852353-71047808	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 71.2;endometrium 1: 65.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.9;HAP1: 10.5;HDLM-2: 15.9;HEL: 7.7;T-47d: 36.6"	"Group enriched"	"Detected in some"	7	"breast cancer: 4.1;renal cancer: 9.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	49	"basophil: 22.4"	"Lineage enriched"	"Detected in single"	49	"granulocytes: 22.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010689	Uncertain									"HPA010689: AB_1855883"	"unprognostic (1.53e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (3.50e-4)"	"unprognostic (8.83e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.41e-4)"	32.5	3.0	3.9	6.8	0.7	0.0	71.2	0.2	1.7	7.8	6.3	0.1	3.0	0.5	65.2	16.6	1.7	4.8	11.3	2.6	0.6	2.0	41.5	0.3	0.6	2.2	0.4	1.4	2.4	10.7	0.0	0.4	0.5	1.6	3.3	1.0	0.1	15.5	3.7	0.5	6.2	1.8	31.9	0.5	0.3	9.1	4.0	0.0	0.0	0.7	3.2	0.7	4.4	5.7	0.0	0.4	22.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.9	0.3	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.7	0.0	10.5	0.0	0.0	15.9	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.1	0.0	36.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	0.0	22.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.7	0.2	1.7	0.6	2.0	0.4	1.4	1.6	0.0
RAMP1		ENSG00000132329	"Receptor activity modifying protein 1"	O60894	2	237858893-237912114	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 91.6;pancreas: 94.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.8;HDLM-2: 37.1;PC-3: 43.2;SH-SY5Y: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	16	"NK-cell: 30.0"	"Lineage enriched"	"Detected in many"	16	"NK-cells: 30.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057814			Approved	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"	"Nucleoplasm, Nuclear membrane"	"HPA057814: AB_2683536"	"unprognostic (1.13e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.29e-1)"	"unprognostic (1.75e-1)"	"prognostic favourable (7.61e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.45e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.46e-3)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.08e-3)"	3.5	13.8	22.4	9.4	23.9	1.2	1.6	7.8	22.5	34.1	38.8	9.9	8.9	24.9	91.6	21.7	8.9	29.1	19.0	61.7	19.6	15.4	3.1	13.4	3.1	3.3	18.0	12.7	8.4	94.7	1.0	1.6	4.5	14.6	25.5	3.5	1.5	1.5	25.1	62.4	2.4	14.4	51.8	19.5	2.4	14.2	4.3	17.1	0.0	1.1	5.4	2.0	18.3	14.0	0.1	0.4	0.2	0.0	30.0	1.8	1.4	7.7	0.0	0.1	0.0	3.4	5.2	0.3	0.5	0.9	0.5	0.4	0.0	12.8	0.0	0.1	0.2	0.0	2.0	0.0	0.0	37.1	1.0	0.0	0.0	0.2	10.4	0.0	0.0	4.0	6.1	0.0	0.0	0.0	0.0	0.1	1.0	0.7	0.0	0.3	0.1	43.2	0.0	0.4	0.2	0.0	0.0	0.4	54.4	0.8	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.2	0.1	0.2	30.0	0.0	0.0	0.0	1.4	22.4	23.9	7.8	15.3	19.6	15.4	18.0	12.7	14.6	17.1
RAP2C	DKFZp313B211	ENSG00000123728	"RAP2C, member of RAS oncogene family"	Q9Y3L5	X	132203024-132219480	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 65.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.37e-2)"	"unprognostic (8.80e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavourable (3.81e-5)"	"unprognostic (2.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.00e-1)"	8.2	7.3	5.7	8.1	7.6	20.0	6.4	3.4	4.7	14.7	9.2	6.4	4.5	7.1	65.2	14.4	9.0	9.5	6.8	10.9	5.2	5.1	13.6	19.8	9.2	9.7	6.9	3.2	8.6	7.0	3.1	3.2	12.7	5.6	6.8	6.5	6.9	6.4	7.4	17.4	6.6	8.6	27.7	8.0	12.4	6.6	7.6	5.6	10.5	8.4	7.4	11.3	12.0	6.8	6.0	5.4	11.3	16.3	7.4	7.5	4.6	12.2	9.5	14.1	15.6	12.1	19.8	21.9	13.9	17.4	13.5	13.8	9.5	16.3	17.4	22.1	15.5	9.1	12.9	13.5	17.7	31.2	11.7	13.4	11.0	13.5	18.5	22.2	18.9	15.7	15.6	15.1	16.4	15.0	10.7	20.6	14.8	19.5	12.5	17.6	9.6	13.8	9.7	10.8	17.5	17.8	9.0	2.9	15.8	8.3	9.9	14.8	17.1	12.1	13.3	13.9	8.1	28.4	25.2	19.2	15.1	17.8	15.7	21.5	12.3	6.5	4.8	11.3	6.0	10.3	6.9	6.0	6.8	6.2	5.4	5.0	6.3	7.5	9.6	7.4	16.3	2.6	6.8	4.6	5.7	7.6	3.4	4.7	5.2	5.1	6.9	3.2	5.6	5.6
RERG	MGC15754	ENSG00000134533	"RAS like estrogen regulated growth inhibitor"	Q96A58	12	15107783-15348675	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 73.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.1;BEWO: 18.4;T-47d: 35.2;U-2 OS: 11.8"	"Cancer enhanced"	"Detected in all"		"breast cancer: 19.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"myeloid DC: 1.5"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041387	Approved									"HPA041387: AB_10796669"	"unprognostic (5.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.72e-2)"	"prognostic unfavourable (7.56e-4)"	"unprognostic (8.72e-2)"	"unprognostic (9.42e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.61e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	12.6	21.9	3.5	8.2	23.9	0.2	22.8	0.8	9.3	31.9	14.5	0.8	24.6	2.0	73.6	43.2	7.3	29.0	6.7	6.0	4.2	4.8	19.5	1.3	7.8	2.0	4.3	4.1	23.6	5.1	0.9	0.9	15.4	17.6	12.6	4.6	2.9	6.0	38.9	3.5	4.2	7.4	40.3	2.3	15.2	9.8	11.7	3.5	0.0	2.6	2.8	1.8	15.7	10.6	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.1	8.1	3.3	0.2	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.7	0.0	0.0	0.1	0.1	0.0	0.0	2.3	0.0	3.2	0.0	2.6	0.0	1.0	0.4	0.5	0.0	1.2	0.0	0.3	0.0	0.7	0.3	0.1	0.1	0.9	0.4	0.0	0.0	0.1	3.1	0.1	0.0	1.2	1.3	1.4	0.0	35.2	0.0	0.0	0.5	11.8	0.2	0.1	0.1	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	23.9	0.8	9.3	4.2	4.8	4.3	4.1	17.6	3.5
RSPO1	"FLJ40906, RSPONDIN"	ENSG00000169218	"R-spondin 1"	Q2MKA7	1	37611350-37634923	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 17.3;endometrium 1: 26.6"	"Group enriched"	"Detected in some"	5	"HHSteC: 1.7;NTERA-2: 4.5;THP-1: 4.6"	"Cancer enriched"	"Detected in some"	13	"ovarian cancer: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA046154	Uncertain				"Secreted in female reproductive system"					"HPA046154: AB_10964912"	"unprognostic (1.50e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.99e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.75e-6)"		"unprognostic (1.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.13e-2)"		"unprognostic (1.93e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-2)"	5.0	0.1	0.2	1.9	0.3	0.0	5.8	0.5	0.6	17.3	2.1	0.2	0.2	0.6	26.6	3.0	1.8	15.8	12.2	0.4	0.2	0.0	0.7	0.2	4.5	1.9	0.2	0.2	7.5	1.6	0.0	0.2	1.3	0.4	3.0	0.2	2.3	1.5	1.4	0.2	4.0	3.1	10.9	0.2	0.7	2.0	1.0	0.2	0.2	0.2	1.3	6.1	1.3	8.8	0.4	0.3	0.7	0.5	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	4.6	0.4	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.7	0.2	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.4	0.2	0.1	0.7	0.0	0.5	0.3	0.3	0.0	0.2	0.3	0.5	0.6	0.2	0.0	0.2	0.2	0.4	0.2
RTL3	"FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5"	ENSG00000179300	"Retrotransposon Gag like 3"	Q8N8U3	X	78656069-78659328	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.5;intestine: 2.6;smooth muscle: 2.7;stomach 1: 3.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.4;BJ hTERT+ SV40 Large T+ RasG12V: 2.6;fHDF/TERT166: 4.0;HBF TERT88: 5.4;hTEC/SVTERT24-B: 3.9;RH-30: 4.7;U-251 MG: 3.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA051991, HPA053174, HPA075136"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737"	"unprognostic (3.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"			"unprognostic (6.74e-2)"		"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.00e-6)"	"unprognostic (1.53e-2)"	"unprognostic (3.64e-1)"		"unprognostic (2.49e-1)"	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	2.6			0.2	2.5	0.2	0.5	0.4	0.5	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0		0.2	0.2	0.0	0.0	0.0		0.2	0.5		0.7	0.0	0.1	0.3	1.1	2.7	0.0	0.0	3.2	0.0			0.1		0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.9	2.4	2.6	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	1.4	0.2	3.4	0.2	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SERTM1	C13orf36	ENSG00000180440	"Serine rich and transmembrane domain containing 1"	A2A2V5	13	36673912-36697839	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 30.2;endometrium 1: 30.9;fallopian tube: 25.3"	"Group enriched"	"Detected in some"	5	"HAP1: 2.6;HEK 293: 3.1;NTERA-2: 7.9;SH-SY5Y: 4.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.7"	"Group enriched"	"Detected in many"	7	"amygdala: 13.9;basal ganglia: 10.1;cerebral cortex: 21.6;hippocampal formation: 26.5;olfactory region: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054814, HPA070485"	Uncertain		Enhanced	Vesicles				Vesicles	Vesicles	"HPA054814: AB_2682611, HPA070485: AB_2686272"	"unprognostic (8.71e-2)"	"unprognostic (2.11e-1)"		"unprognostic (5.58e-3)"	"unprognostic (4.66e-3)"			"unprognostic (4.05e-3)"		"unprognostic (5.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.00e-8)"	"unprognostic (2.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.44e-2)"		5.0	1.8	13.9	0.5	10.1	0.5	1.2	0.3	30.2	16.4	0.7	1.3	1.8	0.6	30.9	13.5	0.5	25.3	0.5	0.6	26.5	2.0	0.6	0.5	5.6	0.5	1.5	11.6	14.5	0.8	1.0	11.2	0.5	2.4	0.9	0.5	8.2	0.5	1.2	0.5	0.6	0.6	17.4	0.9	0.5	0.9	1.5	0.0	0.0	9.3	0.0	0.5	1.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	3.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	10.1	0.3	21.6	26.5	2.0	1.5	11.6	2.4	0.0
SFRP4	"FRP-4, frpHE, FRZB-2"	ENSG00000106483	"Secreted frizzled related protein 4"	Q6FHJ7	7	37905932-38025695	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 144.9;endometrium 1: 100.7;retina: 123.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 13.8;HSkMC: 5.4;U-937: 5.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA009712, HPA050585"	Enhanced				"Secreted in female reproductive system"	1500000	1500000			"HPA009712: AB_1856778, HPA050585: AB_2681183"	"unprognostic (5.93e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.36e-5)"	"unprognostic (7.37e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.89e-3)"	4.6	2.3	0.5	0.9	0.9	0.0	12.5	0.3	0.4	144.9	0.8	1.7	5.4	0.0	100.7	11.5	3.2	35.1	2.5	5.5	0.4	0.4	1.2	0.2	3.9	0.8	0.8	0.7	42.7	1.4	0.1	4.0	0.4	1.3	4.9	0.2	123.0	2.3	7.1	1.4	0.3	0.5	14.5	3.3	4.1	0.5	5.8	0.3	0.4	3.3	2.5	0.5	8.8	14.8	0.4	0.8	0.4	0.6	0.1	0.1	0.0	0.0	2.5	2.8	0.0	13.8	0.6	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	2.9	0.1	0.0	0.3	0.3	0.0	0.0	0.2	0.2	2.0	0.1	0.4	0.0	5.4	0.7	0.6	0.0	0.2	0.0	0.3	0.2	0.4	0.0	1.6	0.1	0.0	0.2	1.7	0.0	0.1	0.2	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.9	0.0	1.2	1.6	0.2	0.5	0.1	0.2	0.3	5.2	0.9	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.8	0.0	0.0	0.5	0.9	0.3	0.4	0.4	0.4	0.8	0.7	1.3	0.3
SHISAL1	KIAA1644	ENSG00000138944	"Shisa like 1"	Q3SXP7	22	44243667-44312851	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 22.5;endometrium 1: 34.2;smooth muscle: 31.9"	"Cell line enhanced"	"Detected in some"		"SiHa: 16.7;U-2197: 37.9;U-87 MG: 22.0;WM-115: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051178	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA051178: AB_2681374"	"unprognostic (4.07e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.48e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.99e-4)"	"unprognostic (1.10e-4)"	0.7	1.3	13.8	1.3	3.6	0.0	0.5	1.6	13.0	22.5	7.7	0.5	6.9	1.4	34.2	4.5	1.5	1.9	2.3	0.5	5.4	9.1	0.5	0.5	0.6	0.5	3.6	0.5	1.7	0.6	0.1	0.8	5.7	0.5	5.8	1.5	0.5	0.5	8.9	0.5	0.4	0.8	31.9	0.5	0.5	0.5	1.5	0.5	0.5	0.5	0.5	0.5	11.9	3.3	0.0	0.1	0.7	0.0	0.2	0.1	0.0	0.0	0.1	1.6	0.5	0.0	0.0	0.0	0.4	1.1	1.1	0.6	0.0	0.0	0.0	0.0	1.0	0.0	2.3	0.1	0.1	0.0	1.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	6.1	0.0	16.7	0.0	0.1	0.0	0.1	0.0	6.2	0.9	37.9	0.2	0.0	0.0	0.0	22.0	0.0	12.7	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.0	13.8	3.6	1.6	11.8	5.4	9.1	3.6	0.5	0.5	0.5
SNCAIP	SYPH1	ENSG00000064692	"Synuclein alpha interacting protein"	Q9Y6H5	5	122311354-122464219	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 22.6;ovary: 32.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.7;BJ hTERT+: 7.4;HBF TERT88: 4.8;RPMI-8226: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"basophil: 9.9"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064687	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"				"Cytoplasmic bodies"	"Cytoplasmic bodies"	"HPA064687: AB_2685324"	"unprognostic (7.28e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-1)"	3.9	1.2	2.2	2.1	5.8	0.7	4.1	15.4	6.4	16.0	1.6	3.7	4.0	1.6	22.6	4.3	0.9	4.5	2.4	1.5	3.4	2.2	1.6	0.4	1.4	4.5	1.6	2.4	32.3	0.7	0.3	1.6	2.1	3.2	2.6	1.1	2.3	0.8	2.7	0.7	1.9	1.1	10.6	1.5	6.1	1.2	11.6	2.1	0.5	1.2	3.3	1.4	4.6	4.1	0.4	0.4	9.9	0.3	0.1	0.4	0.0	0.0	0.1	7.7	0.2	0.0	0.5	0.5	3.5	7.4	1.3	0.4	0.5	0.6	0.1	0.3	3.4	0.2	3.0	0.5	4.8	2.8	1.0	0.0	0.6	0.4	0.1	0.0	0.4	0.6	0.1	0.6	0.4	2.3	0.0	2.0	0.0	0.0	0.2	0.1	3.7	0.6	0.2	0.0	7.9	0.3	1.0	1.5	0.3	0.0	0.7	0.0	0.6	0.2	0.8	0.4	1.0	0.5	0.8	0.2	0.2	0.3	0.4	0.0	0.5	9.9	0.3	0.0	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.4	0.2	0.4	1.7	0.1	0.1	0.4	0.1	0.0	2.2	5.8	15.4	4.3	3.4	2.2	1.6	2.4	3.2	2.1
SYTL4		ENSG00000102362	"Synaptotagmin like 4"	Q96C24	X	100674491-100732123	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 36.2;ovary: 47.3;pituitary gland: 41.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 14.9;HMC-1: 30.9;RT4: 20.3;TIME: 17.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 5.1"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 5.1"	"Region enriched"	"Detected in single"	5	"hypothalamus: 35.1"	"Not detected"	"Not detected"			"HPA001475, HPA001589, HPA075138"	Approved		Approved	Vesicles		6100000	6100000	Vesicles	Vesicles	"HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: "	"unprognostic (7.82e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.62e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.60e-2)"	3.8	3.1	9.1	2.8	9.5	1.6	4.4	4.3	8.4	18.1	5.3	6.6	4.8	1.7	36.2	5.4	2.6	10.0	2.9	2.1	11.9	6.0	4.2	7.1	3.0	0.7	9.8	2.7	47.3	8.8	1.3	41.9	2.6	9.4	9.2	6.8	1.3	3.8	6.0	4.5	1.4	3.0	22.5	7.8	2.3	5.3	7.8	9.5	0.0	6.2	1.1	1.4	4.3	9.4	0.5	0.3	5.1	0.3	0.5	0.4	2.3	0.1	3.0	0.8	0.0	4.4	2.5	0.0	3.8	2.5	4.1	7.4	0.3	3.8	0.0	1.0	2.7	3.4	14.9	1.3	4.4	0.0	1.3	0.0	5.1	0.2	1.1	0.0	30.9	0.9	0.3	3.7	0.2	10.4	1.4	0.0	1.9	1.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	3.7	20.3	7.5	0.3	1.5	5.9	0.8	3.6	0.3	17.5	2.1	4.7	10.7	0.9	0.0	0.0	0.0	2.7	0.0	2.4	1.1	0.3	0.5	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.5	0.4	0.2	5.1	0.5	0.2	0.3	0.1	2.3	9.1	9.5	4.3	8.4	11.9	6.0	9.8	2.7	9.4	9.5
TBC1D3	"DKFZp434P2235, PRC17, TBC1D3A"	ENSG00000274611	"TBC1 domain family member 3"	Q8IZP1	17	38181659-38192541	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 3.4;intestine: 5.5;lymphoid tissue: 3.5;testis: 5.5"	"Cell line enhanced"	"Detected in some"		"AF22: 9.0;REH: 5.6;U-138 MG: 7.8;U-266/70: 12.1;U-266/84: 4.7;U-698: 6.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "																		0.0	0.0		0.0		0.0	0.0		0.0	1.5	0.5			0.0	3.4	0.0	0.0	0.0	1.5	0.0			0.1	0.0	0.0	1.7			0.0	0.0	0.0		0.0		2.9	1.9		0.0	0.0	0.0	0.2	5.5	0.0		0.0	0.0	5.5			0.0		3.5	0.0		0.0	0.0	2.2	0.0	0.0	0.9	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.6	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	12.1	4.7	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0										
TCF23	"bHLHa24, OUT"	ENSG00000163792	"Transcription factor 23"	Q7RTU1	2	27149004-27156974	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 28.0;endometrium 1: 56.4;ovary: 49.9"	"Cell line enriched"	"Detected in single"	10	"THP-1: 8.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA044596			Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA044596: "	"unprognostic (1.04e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.41e-5)"	"unprognostic (7.58e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.58e-4)"	"unprognostic (2.64e-2)"	0.3	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	28.0	0.5	0.0	0.5	0.0	56.4	7.2	0.1	14.0	0.4	0.6	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	49.9	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	16.7	0.1	6.2	0.1	7.5	0.0	0.0	0.1	0.0	0.0	0.7	1.5	1.8	1.4	4.4	1.0	1.3	1.2	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.3	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.0	0.5	0.1	0.6	0.3	0.1	0.8	0.1	0.7	0.0	0.3	0.2	0.1	0.2	0.3	0.0	0.3	8.6	0.0	0.2	0.2	0.3	0.2	0.1	0.0	0.2	0.1	0.3	0.0	4.4	1.0	0.9	1.0	0.5	0.8	1.1	1.1	0.8	0.2	1.8	1.2	1.0	3.9	1.3	0.5	1.4	0.6	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
TMEM158	"p40BBp, RIS1"	ENSG00000249992	"Transmembrane protein 158 (gene/pseudogene)"	Q8WZ71	3	45224466-45226278	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.8;endometrium 1: 31.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 65.0;U-138 MG: 27.5;U-87 MG: 90.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 46.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 85.5"	"Low region specificity"	"Detected in all"			HPA074974	Approved									"HPA074974: AB_2732274"	"unprognostic (3.84e-1)"	"unprognostic (9.83e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.77e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.31e-2)"	"unprognostic (4.67e-3)"	"unprognostic (6.23e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.84e-3)"	"prognostic favourable (6.43e-5)"	"prognostic unfavourable (5.42e-9)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.49e-3)"	1.8	6.4	16.4	4.5	46.8	2.2	2.3	2.1	10.9	13.1	3.4	2.3	18.5	1.4	31.1	7.3	21.3	2.0	11.0	0.8	9.0	11.2	1.9	1.2	1.0	1.1	2.5	5.0	1.7	2.4	0.7	5.7	1.4	2.6	15.6	2.7	0.5	1.3	27.0	2.4	2.7	1.2	19.6	1.8	0.8	2.2	3.0	4.3	0.0	0.7	0.8	1.7	6.7	1.6	0.0	0.0	0.9	0.1	0.0	0.0	1.1	2.3	0.4	0.8	0.1	1.5	3.7	0.7	6.0	65.0	3.3	5.4	0.1	0.1	0.0	0.3	2.0	3.3	1.0	0.2	9.9	0.1	0.3	0.0	1.2	0.0	2.1	0.4	1.2	4.9	0.1	6.6	0.5	0.3	14.8	0.1	5.9	0.1	0.0	4.1	7.3	9.0	0.0	0.2	0.9	1.3	2.2	1.2	0.2	2.3	0.0	0.3	0.0	0.8	0.9	27.5	2.0	17.3	20.8	0.0	0.0	0.0	90.2	2.3	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	16.4	46.8	2.1	10.9	9.0	11.2	2.5	5.0	2.6	4.3
TMEM200A	"KIAA1913, TTMC"	ENSG00000164484	"Transmembrane protein 200A"	Q86VY9	6	130365734-130443063	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 36.2"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 20.9;hTEC/SVTERT24-B: 33.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 1.8;NK-cell: 7.1"	"Group enriched"	"Detected in many"	8	"NK-cells: 7.1;T-cells: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014396	Uncertain									"HPA014396: AB_2204904"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.19e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.27e-1)"	"prognostic favourable (3.92e-4)"	"unprognostic (1.27e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-3)"	6.0	17.0	4.6	7.6	2.7	0.0	5.6	0.6	6.2	12.1	7.1	1.5	0.0	4.7	36.2	8.1	1.9	10.6	4.2	4.3	3.1	2.2	14.4	1.2	7.0	3.9	1.1	2.5	26.0	3.9	0.4	11.6	2.1	1.4	4.3	15.1	6.8	2.0	0.8	2.6	2.3	5.3	13.5	0.9	1.2	3.9	7.8	0.2	7.4	3.6	0.3	2.1	8.7	4.0	0.5	0.0	0.0	0.0	7.1	1.8	0.4	0.0	0.0	0.1	0.0	6.0	7.6	0.0	5.2	6.4	5.6	9.9	8.1	0.0	0.0	0.0	10.9	1.2	0.5	0.0	20.9	7.4	0.0	0.0	0.0	0.3	2.7	0.1	0.0	8.5	0.0	33.7	6.8	0.2	0.0	0.7	2.6	0.0	0.0	0.0	4.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	6.4	2.0	0.5	0.9	4.1	0.0	0.0	3.8	0.0	0.6	0.0	0.0	0.0	0.6	0.0	1.0	0.5	1.8	1.0	0.0	0.1	0.3	0.1	0.0	7.1	0.0	0.0	0.0	0.4	4.6	2.7	0.6	6.2	3.1	2.2	1.1	2.5	1.4	0.2
TMEM215		ENSG00000188133	"Transmembrane protein 215"	Q68D42	9	32783499-32787399	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 8.0;retina: 6.5;testis: 17.9"	"Group enriched"	"Detected in some"	6	"NTERA-2: 6.4;SH-SY5Y: 1.9"	"Cancer enriched"	"Detected in single"	14	"thyroid cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052804, HPA063207"	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"				Nucleoplasm	Nucleoplasm	"HPA052804: AB_2681957, HPA063207: AB_2732697"	"unprognostic (1.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.38e-3)"		"unprognostic (2.17e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.83e-2)"		"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-2)"		0.1	0.0	1.8	0.4	1.5	0.0	0.1	0.1	0.9	1.9	0.0	0.0	0.0	0.0	8.0	0.9	0.1	0.1	0.0	0.9	0.9	1.5	0.0	0.0	0.1	0.0	1.7	0.2	0.7	0.0	0.0	0.1	0.0	0.6	0.1	0.0	6.5	0.1	0.0	0.3	0.1	0.1	0.0	1.0	0.0	0.0	17.9	0.0	0.0	3.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.1	0.8	0.9	1.5	1.7	0.2	0.6	0.0
TMSB15B		ENSG00000269226	"Thymosin beta 15B"		X	104063871-104076212	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"endometrium 1: 4.2;ovary: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 11.2;AN3-CA: 10.6;Karpas-707: 11.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (5.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.89e-2)"		"unprognostic (1.04e-1)"	"unprognostic (3.12e-1)"	"unprognostic (6.46e-2)"	"unprognostic (9.11e-3)"	"unprognostic (2.61e-2)"	"unprognostic (4.07e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.07e-2)"	0.5	0.0		1.0		0.4	0.7		1.9	1.3	0.0			0.0	4.2	0.8	0.4	0.9	1.1	0.0			0.0	0.0	0.2	1.1			6.7	0.0	0.5		0.0		1.6	0.4		0.0	1.0	0.0	0.4	0.2	1.8		0.5	0.6	0.0			0.0		1.1	0.5		2.3	1.4	2.4	0.6	3.6	2.4	0.6	0.0	0.4	11.2	10.6	2.0	2.9	0.3	3.3	1.6	1.6	2.4	0.5	0.2	2.3	1.2	0.8	0.1	0.1	0.0	2.3	1.2	2.2	0.6	0.2	0.0	1.1	0.3	1.0	1.9	0.6	1.9	0.6	3.3	0.2	11.6	2.9	0.6	7.0	0.1	3.0	1.8	6.4	2.7	1.5	2.5	1.4	1.8	7.9	0.2	0.0	0.4	0.1	1.1	6.5	3.7	1.9	1.8	2.7	0.8	0.1	2.2	1.5	0.5	1.6	2.4	0.6	0.5	1.0	0.4	0.5	2.3	1.0	0.8	0.4	1.9	2.4	2.1	1.5	3.6	0.4	1.4	0.3	0.6										
TNFAIP8L3	FLJ41287	ENSG00000183578	"TNF alpha induced protein 8 like 3"	Q5GJ75	15	51056598-51105276	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 47.0;smooth muscle: 47.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 12.6;ASC TERT1: 32.2;HUVEC TERT2: 27.5;LHCN-M2: 25.8;TIME: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077484	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA077484: AB_2732347"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.54e-2)"	"unprognostic (9.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavourable (3.51e-4)"	4.6	2.4	11.8	4.1	3.8	0.8	10.5	0.6	5.8	9.8	4.1	1.8	2.8	1.2	47.0	9.9	11.5	20.9	3.7	5.5	11.4	3.1	1.9	1.5	6.6	5.4	1.9	5.6	17.5	1.6	0.6	1.8	1.4	3.3	6.6	5.0	0.6	1.9	3.5	2.1	10.7	3.2	47.0	1.5	14.7	2.9	3.4	1.1	0.0	2.5	4.7	2.4	12.3	18.8	1.4	1.0	3.7	1.5	1.7	0.8	0.3	0.0	0.1	0.0	0.0	12.6	32.2	0.1	0.1	0.0	0.3	0.5	0.0	0.3	0.0	0.6	1.7	0.0	0.4	0.3	0.1	0.0	0.3	0.0	0.9	2.0	3.3	0.1	0.7	11.8	2.5	2.4	9.3	27.5	0.0	0.0	25.8	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	36.8	2.9	0.2	9.4	0.7	0.1	0.0	0.0	6.0	0.0	0.0	2.8	1.5	0.7	0.5	0.7	0.6	0.8	0.6	0.5	0.3	1.4	0.6	0.8	3.7	1.7	1.0	1.0	0.4	0.3	11.8	3.8	0.6	5.8	11.4	3.1	1.9	5.6	3.3	1.1
TRH		ENSG00000170893	"Thyrotropin releasing hormone"	P20396	3	129974305-129977938	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.9;cervix, uterine: 23.6;endometrium 1: 17.5"	"Cell line enhanced"	"Detected in some"		"REH: 3.1;T-47d: 2.9"	"Cancer enhanced"	"Detected in some"		"breast cancer: 13.3;endometrial cancer: 10.2"	"Group enriched"	"Detected in many"	14	"hypothalamus: 33.9;pons and medulla: 33.8"	"Group enriched"	"Detected in some"	11	"intermediate monocyte: 1.1;non-classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Group enriched"	"Detected in many"	5	"hypothalamus: 204.6;olfactory region: 182.2"	"Low region specificity"	"Detected in many"			HPA035596	Enhanced				"Secreted in other tissues"					"HPA035596: AB_2674695"	"unprognostic (1.22e-1)"	"unprognostic (8.94e-2)"		"unprognostic (5.82e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.82e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	0.3	0.1	0.4	0.2	2.4	2.8	0.9	0.3	1.7	23.6	0.1	0.1	0.6	0.2	17.5	0.1	0.1	2.3	0.1	0.5	2.0	33.9	0.1	0.1	0.6	0.1	0.4	0.8	3.2	0.1	0.1	0.1	0.3	33.8	0.1	0.1	6.3	1.0	0.2	0.2	0.5	0.1	0.4	3.6	0.1	0.1	0.8	0.0	0.8	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	2.9	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	2.4	0.3	1.7	2.0	33.9	0.4	0.8	33.8	0.0
TRPC4	"HTRP4, TRP4"	ENSG00000133107	"Transient receptor potential cation channel subfamily C member 4"	Q9UBN4	13	37636636-37870425	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.0;smooth muscle: 17.2"	"Cell line enhanced"	"Detected in some"		"AF22: 7.0;BJ: 16.4;BJ hTERT+ SV40 Large T+: 7.0;fHDF/TERT166: 15.6;U-2197: 7.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (4.52e-4)"	"unprognostic (9.99e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-6)"	"unprognostic (3.73e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.43e-2)"	1.3	0.8	4.6	1.2	4.0	0.2	0.6	2.1	4.0	5.5	4.1	0.6	6.9	0.8	31.0	2.1	0.4	1.9	4.5	1.9	4.8	2.1	3.0	0.5	4.2	0.3	2.5	0.4	3.8	1.8	0.7	0.5	4.6	3.9	9.5	1.1	0.1	0.5	12.6	0.4	0.5	1.6	17.2	2.5	0.5	3.6	0.8	2.5	0.0	1.1	0.0	0.3	3.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	1.1	2.3	0.0	16.4	2.2	7.0	3.8	0.0	0.2	0.0	0.0	15.6	0.0	0.1	0.0	3.5	0.0	0.1	0.0	0.3	0.0	2.7	0.0	0.0	1.0	0.0	2.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.1	7.4	1.4	3.9	0.9	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.0	2.1	4.0	4.8	2.1	2.5	0.4	3.9	2.5
WNT2	"INT1L1, IRP"	ENSG00000105989	"Wnt family member 2"	P09544	7	117276631-117323289	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 10.4;lung: 10.9;placenta: 40.9"	"Cell line enriched"	"Detected in some"	5	"U-2197: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 12.6"	"Low region specificity"	"Detected in all"			HPA020920			Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA020920: "	"unprognostic (1.90e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-1)"	1.8	0.0	0.2	0.1	1.1	0.0	1.4	0.3	2.3	3.0	0.2	0.4	0.4	0.0	10.4	2.7	0.4	1.0	0.2	0.7	0.9	0.9	0.3	0.8	10.9	0.0	0.1	0.5	0.8	0.1	0.0	0.2	40.9	0.5	7.6	0.0	0.9	0.1	0.5	0.0	1.1	0.2	1.2	0.2	1.5	0.1	0.7	0.0	0.0	0.2	0.0	0.1	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.4	2.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.3	2.3	0.9	0.9	0.1	0.5	0.5	0.0
WT1	"AWT1, GUD, NPHS4, WAGR, WIT-2"	ENSG00000184937	"Wilms tumor 1"	P19544	11	32387775-32435630	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 69.0;fallopian tube: 34.5;ovary: 53.4"	"Cell line enhanced"	"Detected in some"		"HEL: 13.2;HMC-1: 17.0;K-562: 11.9;NB-4: 31.9;THP-1: 15.3"	"Cancer enriched"	"Detected in many"	14	"ovarian cancer: 55.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 0.5"	"Low region specificity"	"Detected in single"			"CAB000327, HPA035717, HPA053848"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: "	"unprognostic (3.09e-3)"	"unprognostic (9.97e-4)"	"unprognostic (3.32e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.31e-10)"	"unprognostic (2.65e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.30e-2)"	10.3	0.0	0.2	1.8	0.6	0.0	0.2	0.2	0.5	20.3	1.5	0.2	3.7	0.0	69.0	9.3	0.4	34.5	0.8	2.1	0.9	0.0	5.3	0.2	0.8	0.5	0.2	0.2	53.4	0.2	0.0	0.2	6.9	0.3	0.9	0.0	0.2	0.2	4.2	0.2	0.0	0.4	23.7	0.2	14.6	0.0	24.5	0.2	0.2	0.3	0.2	0.2	1.3	4.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.1	0.0	0.0	6.1	0.0	0.0	0.0	4.6	13.2	0.0	1.1	3.7	8.8	17.0	0.0	0.0	2.7	0.0	0.0	11.9	0.1	2.7	0.0	7.7	31.9	0.7	3.7	1.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	15.3	0.1	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.2	0.5	0.9	0.0	0.2	0.2	0.3	0.2
